id	sid	tid	token	lemma	pos
ajbspi-34503	1	1	volume	volume	NOUN
ajbspi-34503	1	2	04	04	NUM
ajbspi-34503	1	3	issue	issue	NOUN
ajbspi-34503	1	4	03	03	NUM
ajbspi-34503	1	5	-	-	SYM
ajbspi-34503	1	6	2024	2024	NUM
ajbspi-34503	1	7	9	9	NUM
ajbspi-34503	1	8	american	american	ADJ
ajbspi-34503	1	9	journal	journal	PROPN
ajbspi-34503	1	10	of	of	ADP
ajbspi-34503	1	11	biomedical	biomedical	PROPN
ajbspi-34503	1	12	science	science	PROPN
ajbspi-34503	1	13	&	&	CCONJ
ajbspi-34503	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	1	15	innovation	innovation	NOUN
ajbspi-34503	1	16	(	(	PUNCT
ajbspi-34503	1	17	issn	issn	PROPN
ajbspi-34503	1	18	–	–	PUNCT
ajbspi-34503	1	19	2771	2771	NUM
ajbspi-34503	1	20	-	-	SYM
ajbspi-34503	1	21	2753	2753	NUM
ajbspi-34503	1	22	)	)	PUNCT
ajbspi-34503	1	23	volume	volume	NOUN
ajbspi-34503	1	24	04	04	NUM
ajbspi-34503	1	25	issue	issue	NOUN
ajbspi-34503	1	26	03	03	NUM
ajbspi-34503	1	27	pages	page	NOUN
ajbspi-34503	1	28	:	:	PUNCT
ajbspi-34503	1	29	9	9	NUM
ajbspi-34503	1	30	-	-	SYM
ajbspi-34503	1	31	17	17	NUM
ajbspi-34503	1	32	sjif	sjif	NOUN
ajbspi-34503	1	33	impact	impact	NOUN
ajbspi-34503	1	34	factor	factor	NOUN
ajbspi-34503	1	35	(	(	PUNCT
ajbspi-34503	1	36	2021	2021	NUM
ajbspi-34503	1	37	:	:	PUNCT
ajbspi-34503	1	38	5	5	NUM
ajbspi-34503	1	39	.	.	NOUN
ajbspi-34503	1	40	705	705	NUM
ajbspi-34503	1	41	)	)	PUNCT
ajbspi-34503	1	42	(	(	PUNCT
ajbspi-34503	1	43	2022	2022	NUM
ajbspi-34503	1	44	:	:	PUNCT
ajbspi-34503	1	45	5	5	NUM
ajbspi-34503	1	46	.	.	NOUN
ajbspi-34503	1	47	705	705	NUM
ajbspi-34503	1	48	)	)	PUNCT
ajbspi-34503	1	49	(	(	PUNCT
ajbspi-34503	1	50	2023	2023	NUM
ajbspi-34503	1	51	:	:	PUNCT
ajbspi-34503	1	52	6.534	6.534	NUM
ajbspi-34503	1	53	)	)	PUNCT
ajbspi-34503	1	54	oclc	oclc	PROPN
ajbspi-34503	1	55	–	–	PUNCT
ajbspi-34503	1	56	1121105677	1121105677	NUM
ajbspi-34503	1	57	publisher	publisher	NOUN
ajbspi-34503	1	58	:	:	PUNCT
ajbspi-34503	1	59	oscar	oscar	NOUN
ajbspi-34503	1	60	publishing	publishing	NOUN
ajbspi-34503	1	61	services	service	NOUN
ajbspi-34503	1	62	servi	servi	PROPN
ajbspi-34503	1	63	abstract	abstract	ADJ
ajbspi-34503	1	64	this	this	DET
ajbspi-34503	1	65	study	study	NOUN
ajbspi-34503	1	66	presents	present	VERB
ajbspi-34503	1	67	the	the	DET
ajbspi-34503	1	68	development	development	NOUN
ajbspi-34503	1	69	and	and	CCONJ
ajbspi-34503	1	70	evaluation	evaluation	NOUN
ajbspi-34503	1	71	of	of	ADP
ajbspi-34503	1	72	a	a	DET
ajbspi-34503	1	73	novel	novel	ADJ
ajbspi-34503	1	74	nanoparticle	nanoparticle	NOUN
ajbspi-34503	1	75	-	-	PUNCT
ajbspi-34503	1	76	based	base	VERB
ajbspi-34503	1	77	topical	topical	ADJ
ajbspi-34503	1	78	gel	gel	NOUN
ajbspi-34503	1	79	containing	contain	VERB
ajbspi-34503	1	80	the	the	DET
ajbspi-34503	1	81	antifungal	antifungal	ADJ
ajbspi-34503	1	82	drug	drug	NOUN
ajbspi-34503	1	83	fluconazole	fluconazole	NOUN
ajbspi-34503	1	84	.	.	PUNCT
ajbspi-34503	2	1	the	the	DET
ajbspi-34503	2	2	formulation	formulation	NOUN
ajbspi-34503	2	3	was	be	AUX
ajbspi-34503	2	4	designed	design	VERB
ajbspi-34503	2	5	to	to	PART
ajbspi-34503	2	6	enhance	enhance	VERB
ajbspi-34503	2	7	drug	drug	NOUN
ajbspi-34503	2	8	delivery	delivery	NOUN
ajbspi-34503	2	9	and	and	CCONJ
ajbspi-34503	2	10	efficacy	efficacy	NOUN
ajbspi-34503	2	11	in	in	ADP
ajbspi-34503	2	12	the	the	DET
ajbspi-34503	2	13	treatment	treatment	NOUN
ajbspi-34503	2	14	of	of	ADP
ajbspi-34503	2	15	fungal	fungal	ADJ
ajbspi-34503	2	16	infections	infection	NOUN
ajbspi-34503	2	17	.	.	PUNCT
ajbspi-34503	3	1	the	the	DET
ajbspi-34503	3	2	nanoparticles	nanoparticle	NOUN
ajbspi-34503	3	3	serve	serve	VERB
ajbspi-34503	3	4	as	as	ADP
ajbspi-34503	3	5	carriers	carrier	NOUN
ajbspi-34503	3	6	for	for	ADP
ajbspi-34503	3	7	fluconazole	fluconazole	NOUN
ajbspi-34503	3	8	,	,	PUNCT
ajbspi-34503	3	9	facilitating	facilitate	VERB
ajbspi-34503	3	10	its	its	PRON
ajbspi-34503	3	11	targeted	target	VERB
ajbspi-34503	3	12	delivery	delivery	NOUN
ajbspi-34503	3	13	to	to	ADP
ajbspi-34503	3	14	the	the	DET
ajbspi-34503	3	15	site	site	NOUN
ajbspi-34503	3	16	of	of	ADP
ajbspi-34503	3	17	infection	infection	NOUN
ajbspi-34503	3	18	while	while	SCONJ
ajbspi-34503	3	19	minimizing	minimize	VERB
ajbspi-34503	3	20	systemic	systemic	ADJ
ajbspi-34503	3	21	side	side	NOUN
ajbspi-34503	3	22	effects	effect	NOUN
ajbspi-34503	3	23	.	.	PUNCT
ajbspi-34503	4	1	the	the	DET
ajbspi-34503	4	2	topical	topical	ADJ
ajbspi-34503	4	3	gel	gel	NOUN
ajbspi-34503	4	4	was	be	AUX
ajbspi-34503	4	5	characterized	characterize	VERB
ajbspi-34503	4	6	for	for	ADP
ajbspi-34503	4	7	its	its	PRON
ajbspi-34503	4	8	physicochemical	physicochemical	ADJ
ajbspi-34503	4	9	properties	property	NOUN
ajbspi-34503	4	10	,	,	PUNCT
ajbspi-34503	4	11	drug	drug	NOUN
ajbspi-34503	4	12	release	release	NOUN
ajbspi-34503	4	13	profile	profile	NOUN
ajbspi-34503	4	14	,	,	PUNCT
ajbspi-34503	4	15	and	and	CCONJ
ajbspi-34503	4	16	antifungal	antifungal	ADJ
ajbspi-34503	4	17	activity	activity	NOUN
ajbspi-34503	4	18	.	.	PUNCT
ajbspi-34503	5	1	in	in	ADP
ajbspi-34503	5	2	vitro	vitro	X
ajbspi-34503	5	3	and	and	CCONJ
ajbspi-34503	5	4	in	in	ADP
ajbspi-34503	5	5	vivo	vivo	NOUN
ajbspi-34503	5	6	evaluations	evaluation	NOUN
ajbspi-34503	5	7	demonstrated	demonstrate	VERB
ajbspi-34503	5	8	the	the	DET
ajbspi-34503	5	9	effectiveness	effectiveness	NOUN
ajbspi-34503	5	10	of	of	ADP
ajbspi-34503	5	11	the	the	DET
ajbspi-34503	5	12	nanoformulation	nanoformulation	NOUN
ajbspi-34503	5	13	in	in	ADP
ajbspi-34503	5	14	inhibiting	inhibit	VERB
ajbspi-34503	5	15	fungal	fungal	ADJ
ajbspi-34503	5	16	growth	growth	NOUN
ajbspi-34503	5	17	and	and	CCONJ
ajbspi-34503	5	18	promoting	promote	VERB
ajbspi-34503	5	19	healing	healing	NOUN
ajbspi-34503	5	20	.	.	PUNCT
ajbspi-34503	6	1	the	the	DET
ajbspi-34503	6	2	results	result	NOUN
ajbspi-34503	6	3	suggest	suggest	VERB
ajbspi-34503	6	4	that	that	SCONJ
ajbspi-34503	6	5	the	the	DET
ajbspi-34503	6	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	6	7	-	-	PUNCT
ajbspi-34503	6	8	based	base	VERB
ajbspi-34503	6	9	topical	topical	ADJ
ajbspi-34503	6	10	gel	gel	NOUN
ajbspi-34503	6	11	holds	hold	VERB
ajbspi-34503	6	12	promise	promise	NOUN
ajbspi-34503	6	13	as	as	ADP
ajbspi-34503	6	14	a	a	DET
ajbspi-34503	6	15	promising	promising	ADJ
ajbspi-34503	6	16	antifungal	antifungal	ADJ
ajbspi-34503	6	17	treatment	treatment	NOUN
ajbspi-34503	6	18	with	with	ADP
ajbspi-34503	6	19	potential	potential	ADJ
ajbspi-34503	6	20	clinical	clinical	ADJ
ajbspi-34503	6	21	applications	application	NOUN
ajbspi-34503	6	22	.	.	PUNCT
ajbspi-34503	7	1	keywords	keyword	NOUN
ajbspi-34503	7	2	nanoformulation	nanoformulation	VERB
ajbspi-34503	7	3	,	,	PUNCT
ajbspi-34503	7	4	topical	topical	ADJ
ajbspi-34503	7	5	gel	gel	NOUN
ajbspi-34503	7	6	,	,	PUNCT
ajbspi-34503	7	7	fluconazole	fluconazole	NOUN
ajbspi-34503	7	8	,	,	PUNCT
ajbspi-34503	7	9	antifungal	antifungal	ADJ
ajbspi-34503	7	10	treatment	treatment	NOUN
ajbspi-34503	7	11	,	,	PUNCT
ajbspi-34503	7	12	nanoparticles	nanoparticle	NOUN
ajbspi-34503	7	13	,	,	PUNCT
ajbspi-34503	7	14	drug	drug	NOUN
ajbspi-34503	7	15	delivery	delivery	NOUN
ajbspi-34503	7	16	,	,	PUNCT
ajbspi-34503	7	17	fungal	fungal	ADJ
ajbspi-34503	7	18	infections	infection	NOUN
ajbspi-34503	7	19	.	.	PUNCT
ajbspi-34503	8	1	introduction	introduction	NOUN
ajbspi-34503	8	2	fungal	fungal	ADJ
ajbspi-34503	8	3	infections	infection	NOUN
ajbspi-34503	8	4	represent	represent	VERB
ajbspi-34503	8	5	a	a	DET
ajbspi-34503	8	6	significant	significant	ADJ
ajbspi-34503	8	7	burden	burden	NOUN
ajbspi-34503	8	8	on	on	ADP
ajbspi-34503	8	9	global	global	ADJ
ajbspi-34503	8	10	public	public	ADJ
ajbspi-34503	8	11	health	health	NOUN
ajbspi-34503	8	12	,	,	PUNCT
ajbspi-34503	8	13	affecting	affect	VERB
ajbspi-34503	8	14	millions	million	NOUN
ajbspi-34503	8	15	of	of	ADP
ajbspi-34503	8	16	individuals	individual	NOUN
ajbspi-34503	8	17	worldwide	worldwide	ADV
ajbspi-34503	8	18	.	.	PUNCT
ajbspi-34503	9	1	among	among	ADP
ajbspi-34503	9	2	the	the	DET
ajbspi-34503	9	3	various	various	ADJ
ajbspi-34503	9	4	antifungal	antifungal	ADJ
ajbspi-34503	9	5	agents	agent	NOUN
ajbspi-34503	9	6	available	available	ADJ
ajbspi-34503	9	7	,	,	PUNCT
ajbspi-34503	9	8	fluconazole	fluconazole	NOUN
ajbspi-34503	9	9	stands	stand	VERB
ajbspi-34503	9	10	out	out	ADP
ajbspi-34503	9	11	as	as	ADP
ajbspi-34503	9	12	a	a	DET
ajbspi-34503	9	13	widely	widely	ADV
ajbspi-34503	9	14	used	use	VERB
ajbspi-34503	9	15	drug	drug	NOUN
ajbspi-34503	9	16	due	due	ADP
ajbspi-34503	9	17	to	to	ADP
ajbspi-34503	9	18	its	its	PRON
ajbspi-34503	9	19	broad	broad	ADJ
ajbspi-34503	9	20	-	-	PUNCT
ajbspi-34503	9	21	spectrum	spectrum	NOUN
ajbspi-34503	9	22	activity	activity	NOUN
ajbspi-34503	9	23	and	and	CCONJ
ajbspi-34503	9	24	favorable	favorable	ADJ
ajbspi-34503	9	25	safety	safety	NOUN
ajbspi-34503	9	26	profile	profile	NOUN
ajbspi-34503	9	27	.	.	PUNCT
ajbspi-34503	10	1	however	however	ADV
ajbspi-34503	10	2	,	,	PUNCT
ajbspi-34503	10	3	conventional	conventional	ADJ
ajbspi-34503	10	4	formulations	formulation	NOUN
ajbspi-34503	10	5	of	of	ADP
ajbspi-34503	10	6	fluconazole	fluconazole	NOUN
ajbspi-34503	10	7	often	often	ADV
ajbspi-34503	10	8	face	face	VERB
ajbspi-34503	10	9	challenges	challenge	NOUN
ajbspi-34503	10	10	such	such	ADJ
ajbspi-34503	10	11	as	as	ADP
ajbspi-34503	10	12	poor	poor	ADJ
ajbspi-34503	10	13	research	research	NOUN
ajbspi-34503	10	14	article	article	NOUN
ajbspi-34503	10	15	nanoformulation	nanoformulation	NOUN
ajbspi-34503	10	16	and	and	CCONJ
ajbspi-34503	10	17	evaluation	evaluation	NOUN
ajbspi-34503	10	18	of	of	ADP
ajbspi-34503	10	19	topical	topical	ADJ
ajbspi-34503	10	20	gel	gel	NOUN
ajbspi-34503	10	21	with	with	ADP
ajbspi-34503	10	22	fluconazole	fluconazole	NOUN
ajbspi-34503	10	23	:	:	PUNCT
ajbspi-34503	10	24	a	a	DET
ajbspi-34503	10	25	promising	promising	ADJ
ajbspi-34503	10	26	antifungal	antifungal	ADJ
ajbspi-34503	10	27	treatment	treatment	NOUN
ajbspi-34503	10	28	submission	submission	NOUN
ajbspi-34503	10	29	date	date	NOUN
ajbspi-34503	10	30	:	:	PUNCT
ajbspi-34503	10	31	february	february	PROPN
ajbspi-34503	10	32	21	21	NUM
ajbspi-34503	10	33	,	,	PUNCT
ajbspi-34503	10	34	2024	2024	NUM
ajbspi-34503	10	35	,	,	PUNCT
ajbspi-34503	10	36	accepted	accept	VERB
ajbspi-34503	10	37	date	date	NOUN
ajbspi-34503	10	38	:	:	PUNCT
ajbspi-34503	10	39	february	february	PROPN
ajbspi-34503	10	40	26	26	NUM
ajbspi-34503	10	41	,	,	PUNCT
ajbspi-34503	10	42	2024	2024	NUM
ajbspi-34503	10	43	,	,	PUNCT
ajbspi-34503	10	44	published	publish	VERB
ajbspi-34503	10	45	date	date	NOUN
ajbspi-34503	10	46	:	:	PUNCT
ajbspi-34503	10	47	march	march	NOUN
ajbspi-34503	10	48	02	02	NUM
ajbspi-34503	10	49	,	,	PUNCT
ajbspi-34503	10	50	2024	2024	NUM
ajbspi-34503	10	51	crossref	crossref	NOUN
ajbspi-34503	10	52	doi	doi	NOUN
ajbspi-34503	10	53	:	:	PUNCT
ajbspi-34503	10	54	https://doi.org/10.37547/ajbspi/volume04issue03-02	https://doi.org/10.37547/ajbspi/volume04issue03-02	PROPN
ajbspi-34503	10	55	dr	dr	PROPN
ajbspi-34503	10	56	.	.	PROPN
ajbspi-34503	10	57	c.s.r	c.s.r	PROPN
ajbspi-34503	10	58	.	.	PROPN
ajbspi-34503	10	59	rajani	rajani	PROPN
ajbspi-34503	10	60	department	department	PROPN
ajbspi-34503	10	61	of	of	ADP
ajbspi-34503	10	62	pharmaceutics	pharmaceutic	NOUN
ajbspi-34503	10	63	,	,	PUNCT
ajbspi-34503	10	64	nargund	nargund	PROPN
ajbspi-34503	10	65	college	college	NOUN
ajbspi-34503	10	66	of	of	ADP
ajbspi-34503	10	67	pharmacy	pharmacy	NOUN
ajbspi-34503	10	68	,	,	PUNCT
ajbspi-34503	10	69	bangalore	bangalore	PROPN
ajbspi-34503	10	70	,	,	PUNCT
ajbspi-34503	10	71	india	india	PROPN
ajbspi-34503	10	72	journal	journal	PROPN
ajbspi-34503	10	73	website	website	NOUN
ajbspi-34503	10	74	:	:	PUNCT
ajbspi-34503	10	75	https://theusajournals	https://theusajournals	PROPN
ajbspi-34503	10	76	.	.	PUNCT
ajbspi-34503	10	77	com	com	NOUN
ajbspi-34503	10	78	/	/	SYM
ajbspi-34503	10	79	index.php	index.php	VERB
ajbspi-34503	10	80	/	/	SYM
ajbspi-34503	10	81	ajbspi	ajbspi	NOUN
ajbspi-34503	10	82	copyright	copyright	NOUN
ajbspi-34503	10	83	:	:	PUNCT
ajbspi-34503	10	84	original	original	ADJ
ajbspi-34503	10	85	content	content	NOUN
ajbspi-34503	10	86	from	from	ADP
ajbspi-34503	10	87	this	this	DET
ajbspi-34503	10	88	work	work	NOUN
ajbspi-34503	10	89	may	may	AUX
ajbspi-34503	10	90	be	be	AUX
ajbspi-34503	10	91	used	use	VERB
ajbspi-34503	10	92	under	under	ADP
ajbspi-34503	10	93	the	the	DET
ajbspi-34503	10	94	terms	term	NOUN
ajbspi-34503	10	95	of	of	ADP
ajbspi-34503	10	96	the	the	DET
ajbspi-34503	10	97	creative	creative	ADJ
ajbspi-34503	10	98	commons	common	NOUN
ajbspi-34503	10	99	attributes	attribute	VERB
ajbspi-34503	10	100	4.0	4.0	NUM
ajbspi-34503	10	101	licence	licence	NOUN
ajbspi-34503	10	102	.	.	PUNCT
ajbspi-34503	11	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34503	11	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	11	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	VERB
ajbspi-34503	11	4	https://theusajournals.com/	https://theusajournals.com/	PROPN
ajbspi-34503	11	5	https://doi.org/10.37547/ajbspi/volume04issue03-02	https://doi.org/10.37547/ajbspi/volume04issue03-02	INTJ
ajbspi-34503	11	6	https://doi.org/10.37547/ajbspi/volume04issue03-02	https://doi.org/10.37547/ajbspi/volume04issue03-02	ADJ
ajbspi-34503	11	7	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34503	11	8	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34503	11	9	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34503	11	10	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34503	11	11	volume	volume	NOUN
ajbspi-34503	11	12	04	04	NUM
ajbspi-34503	11	13	issue	issue	NOUN
ajbspi-34503	11	14	03	03	NUM
ajbspi-34503	11	15	-	-	SYM
ajbspi-34503	11	16	2024	2024	NUM
ajbspi-34503	11	17	10	10	NUM
ajbspi-34503	11	18	american	american	ADJ
ajbspi-34503	11	19	journal	journal	PROPN
ajbspi-34503	11	20	of	of	ADP
ajbspi-34503	11	21	biomedical	biomedical	PROPN
ajbspi-34503	11	22	science	science	PROPN
ajbspi-34503	11	23	&	&	CCONJ
ajbspi-34503	11	24	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	11	25	innovation	innovation	NOUN
ajbspi-34503	11	26	(	(	PUNCT
ajbspi-34503	11	27	issn	issn	PROPN
ajbspi-34503	11	28	–	–	PUNCT
ajbspi-34503	11	29	2771	2771	NUM
ajbspi-34503	11	30	-	-	SYM
ajbspi-34503	11	31	2753	2753	NUM
ajbspi-34503	11	32	)	)	PUNCT
ajbspi-34503	11	33	volume	volume	NOUN
ajbspi-34503	11	34	04	04	NUM
ajbspi-34503	11	35	issue	issue	NOUN
ajbspi-34503	11	36	03	03	NUM
ajbspi-34503	11	37	pages	page	NOUN
ajbspi-34503	11	38	:	:	PUNCT
ajbspi-34503	11	39	9	9	NUM
ajbspi-34503	11	40	-	-	SYM
ajbspi-34503	11	41	17	17	NUM
ajbspi-34503	11	42	sjif	sjif	NOUN
ajbspi-34503	11	43	impact	impact	NOUN
ajbspi-34503	11	44	factor	factor	NOUN
ajbspi-34503	11	45	(	(	PUNCT
ajbspi-34503	11	46	2021	2021	NUM
ajbspi-34503	11	47	:	:	PUNCT
ajbspi-34503	11	48	5	5	NUM
ajbspi-34503	11	49	.	.	NOUN
ajbspi-34503	11	50	705	705	NUM
ajbspi-34503	11	51	)	)	PUNCT
ajbspi-34503	11	52	(	(	PUNCT
ajbspi-34503	11	53	2022	2022	NUM
ajbspi-34503	11	54	:	:	PUNCT
ajbspi-34503	11	55	5	5	NUM
ajbspi-34503	11	56	.	.	NOUN
ajbspi-34503	11	57	705	705	NUM
ajbspi-34503	11	58	)	)	PUNCT
ajbspi-34503	11	59	(	(	PUNCT
ajbspi-34503	11	60	2023	2023	NUM
ajbspi-34503	11	61	:	:	PUNCT
ajbspi-34503	11	62	6.534	6.534	NUM
ajbspi-34503	11	63	)	)	PUNCT
ajbspi-34503	11	64	oclc	oclc	PROPN
ajbspi-34503	11	65	–	–	PUNCT
ajbspi-34503	11	66	1121105677	1121105677	NUM
ajbspi-34503	11	67	publisher	publisher	NOUN
ajbspi-34503	11	68	:	:	PUNCT
ajbspi-34503	11	69	oscar	oscar	NOUN
ajbspi-34503	11	70	publishing	publishing	NOUN
ajbspi-34503	11	71	services	service	NOUN
ajbspi-34503	11	72	servi	servi	ADJ
ajbspi-34503	11	73	penetration	penetration	NOUN
ajbspi-34503	11	74	into	into	ADP
ajbspi-34503	11	75	the	the	DET
ajbspi-34503	11	76	skin	skin	NOUN
ajbspi-34503	11	77	layers	layer	NOUN
ajbspi-34503	11	78	,	,	PUNCT
ajbspi-34503	11	79	limited	limited	ADJ
ajbspi-34503	11	80	bioavailability	bioavailability	NOUN
ajbspi-34503	11	81	at	at	ADP
ajbspi-34503	11	82	the	the	DET
ajbspi-34503	11	83	target	target	NOUN
ajbspi-34503	11	84	site	site	NOUN
ajbspi-34503	11	85	,	,	PUNCT
ajbspi-34503	11	86	and	and	CCONJ
ajbspi-34503	11	87	systemic	systemic	ADJ
ajbspi-34503	11	88	side	side	NOUN
ajbspi-34503	11	89	effects	effect	NOUN
ajbspi-34503	11	90	.	.	PUNCT
ajbspi-34503	12	1	to	to	PART
ajbspi-34503	12	2	address	address	VERB
ajbspi-34503	12	3	these	these	DET
ajbspi-34503	12	4	limitations	limitation	NOUN
ajbspi-34503	12	5	,	,	PUNCT
ajbspi-34503	12	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	12	7	-	-	PUNCT
ajbspi-34503	12	8	based	base	VERB
ajbspi-34503	12	9	drug	drug	NOUN
ajbspi-34503	12	10	delivery	delivery	NOUN
ajbspi-34503	12	11	systems	system	NOUN
ajbspi-34503	12	12	have	have	AUX
ajbspi-34503	12	13	emerged	emerge	VERB
ajbspi-34503	12	14	as	as	ADP
ajbspi-34503	12	15	promising	promising	ADJ
ajbspi-34503	12	16	strategies	strategy	NOUN
ajbspi-34503	12	17	to	to	PART
ajbspi-34503	12	18	enhance	enhance	VERB
ajbspi-34503	12	19	the	the	DET
ajbspi-34503	12	20	efficacy	efficacy	NOUN
ajbspi-34503	12	21	and	and	CCONJ
ajbspi-34503	12	22	safety	safety	NOUN
ajbspi-34503	12	23	of	of	ADP
ajbspi-34503	12	24	antifungal	antifungal	ADJ
ajbspi-34503	12	25	treatments	treatment	NOUN
ajbspi-34503	12	26	.	.	PUNCT
ajbspi-34503	13	1	nanoparticles	nanoparticle	NOUN
ajbspi-34503	13	2	offer	offer	VERB
ajbspi-34503	13	3	several	several	ADJ
ajbspi-34503	13	4	advantages	advantage	NOUN
ajbspi-34503	13	5	,	,	PUNCT
ajbspi-34503	13	6	including	include	VERB
ajbspi-34503	13	7	improved	improve	VERB
ajbspi-34503	13	8	drug	drug	NOUN
ajbspi-34503	13	9	stability	stability	NOUN
ajbspi-34503	13	10	,	,	PUNCT
ajbspi-34503	13	11	controlled	control	VERB
ajbspi-34503	13	12	release	release	NOUN
ajbspi-34503	13	13	kinetics	kinetic	NOUN
ajbspi-34503	13	14	,	,	PUNCT
ajbspi-34503	13	15	and	and	CCONJ
ajbspi-34503	13	16	targeted	target	VERB
ajbspi-34503	13	17	delivery	delivery	NOUN
ajbspi-34503	13	18	to	to	ADP
ajbspi-34503	13	19	the	the	DET
ajbspi-34503	13	20	site	site	NOUN
ajbspi-34503	13	21	of	of	ADP
ajbspi-34503	13	22	infection	infection	NOUN
ajbspi-34503	13	23	.	.	PUNCT
ajbspi-34503	14	1	in	in	ADP
ajbspi-34503	14	2	this	this	DET
ajbspi-34503	14	3	context	context	NOUN
ajbspi-34503	14	4	,	,	PUNCT
ajbspi-34503	14	5	the	the	DET
ajbspi-34503	14	6	development	development	NOUN
ajbspi-34503	14	7	of	of	ADP
ajbspi-34503	14	8	a	a	DET
ajbspi-34503	14	9	nanoparticlebased	nanoparticlebase	VERB
ajbspi-34503	14	10	topical	topical	ADJ
ajbspi-34503	14	11	gel	gel	NOUN
ajbspi-34503	14	12	containing	contain	VERB
ajbspi-34503	14	13	fluconazole	fluconazole	NOUN
ajbspi-34503	14	14	presents	present	VERB
ajbspi-34503	14	15	a	a	DET
ajbspi-34503	14	16	compelling	compelling	ADJ
ajbspi-34503	14	17	approach	approach	NOUN
ajbspi-34503	14	18	to	to	PART
ajbspi-34503	14	19	optimize	optimize	VERB
ajbspi-34503	14	20	antifungal	antifungal	ADJ
ajbspi-34503	14	21	therapy	therapy	NOUN
ajbspi-34503	14	22	.	.	PUNCT
ajbspi-34503	15	1	the	the	DET
ajbspi-34503	15	2	aim	aim	NOUN
ajbspi-34503	15	3	of	of	ADP
ajbspi-34503	15	4	this	this	DET
ajbspi-34503	15	5	study	study	NOUN
ajbspi-34503	15	6	is	be	AUX
ajbspi-34503	15	7	to	to	PART
ajbspi-34503	15	8	describe	describe	VERB
ajbspi-34503	15	9	the	the	DET
ajbspi-34503	15	10	formulation	formulation	NOUN
ajbspi-34503	15	11	,	,	PUNCT
ajbspi-34503	15	12	characterization	characterization	NOUN
ajbspi-34503	15	13	,	,	PUNCT
ajbspi-34503	15	14	and	and	CCONJ
ajbspi-34503	15	15	evaluation	evaluation	NOUN
ajbspi-34503	15	16	of	of	ADP
ajbspi-34503	15	17	a	a	DET
ajbspi-34503	15	18	novel	novel	ADJ
ajbspi-34503	15	19	nanoparticle	nanoparticle	NOUN
ajbspi-34503	15	20	-	-	PUNCT
ajbspi-34503	15	21	based	base	VERB
ajbspi-34503	15	22	topical	topical	ADJ
ajbspi-34503	15	23	gel	gel	NOUN
ajbspi-34503	15	24	containing	contain	VERB
ajbspi-34503	15	25	fluconazole	fluconazole	NOUN
ajbspi-34503	15	26	as	as	ADP
ajbspi-34503	15	27	a	a	DET
ajbspi-34503	15	28	promising	promising	ADJ
ajbspi-34503	15	29	antifungal	antifungal	ADJ
ajbspi-34503	15	30	treatment	treatment	NOUN
ajbspi-34503	15	31	.	.	PUNCT
ajbspi-34503	16	1	the	the	DET
ajbspi-34503	16	2	topical	topical	ADJ
ajbspi-34503	16	3	gel	gel	NOUN
ajbspi-34503	16	4	formulation	formulation	NOUN
ajbspi-34503	16	5	offers	offer	VERB
ajbspi-34503	16	6	several	several	ADJ
ajbspi-34503	16	7	advantages	advantage	NOUN
ajbspi-34503	16	8	over	over	ADP
ajbspi-34503	16	9	conventional	conventional	ADJ
ajbspi-34503	16	10	dosage	dosage	NOUN
ajbspi-34503	16	11	forms	form	NOUN
ajbspi-34503	16	12	,	,	PUNCT
ajbspi-34503	16	13	including	include	VERB
ajbspi-34503	16	14	ease	ease	NOUN
ajbspi-34503	16	15	of	of	ADP
ajbspi-34503	16	16	application	application	NOUN
ajbspi-34503	16	17	,	,	PUNCT
ajbspi-34503	16	18	improved	improve	VERB
ajbspi-34503	16	19	patient	patient	ADJ
ajbspi-34503	16	20	compliance	compliance	NOUN
ajbspi-34503	16	21	,	,	PUNCT
ajbspi-34503	16	22	and	and	CCONJ
ajbspi-34503	16	23	enhanced	enhance	VERB
ajbspi-34503	16	24	drug	drug	NOUN
ajbspi-34503	16	25	delivery	delivery	NOUN
ajbspi-34503	16	26	to	to	ADP
ajbspi-34503	16	27	the	the	DET
ajbspi-34503	16	28	site	site	NOUN
ajbspi-34503	16	29	of	of	ADP
ajbspi-34503	16	30	infection	infection	NOUN
ajbspi-34503	16	31	.	.	PUNCT
ajbspi-34503	17	1	the	the	DET
ajbspi-34503	17	2	rationale	rationale	NOUN
ajbspi-34503	17	3	behind	behind	ADP
ajbspi-34503	17	4	developing	develop	VERB
ajbspi-34503	17	5	a	a	DET
ajbspi-34503	17	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	17	7	-	-	PUNCT
ajbspi-34503	17	8	based	base	VERB
ajbspi-34503	17	9	formulation	formulation	NOUN
ajbspi-34503	17	10	lies	lie	VERB
ajbspi-34503	17	11	in	in	ADP
ajbspi-34503	17	12	the	the	DET
ajbspi-34503	17	13	ability	ability	NOUN
ajbspi-34503	17	14	of	of	ADP
ajbspi-34503	17	15	nanoparticles	nanoparticle	NOUN
ajbspi-34503	17	16	to	to	PART
ajbspi-34503	17	17	overcome	overcome	VERB
ajbspi-34503	17	18	the	the	DET
ajbspi-34503	17	19	physiological	physiological	ADJ
ajbspi-34503	17	20	barriers	barrier	NOUN
ajbspi-34503	17	21	associated	associate	VERB
ajbspi-34503	17	22	with	with	ADP
ajbspi-34503	17	23	conventional	conventional	ADJ
ajbspi-34503	17	24	drug	drug	NOUN
ajbspi-34503	17	25	delivery	delivery	NOUN
ajbspi-34503	17	26	systems	system	NOUN
ajbspi-34503	17	27	.	.	PUNCT
ajbspi-34503	18	1	nanoparticles	nanoparticle	NOUN
ajbspi-34503	18	2	can	can	AUX
ajbspi-34503	18	3	penetrate	penetrate	VERB
ajbspi-34503	18	4	the	the	DET
ajbspi-34503	18	5	stratum	stratum	NOUN
ajbspi-34503	18	6	corneum	corneum	NOUN
ajbspi-34503	18	7	and	and	CCONJ
ajbspi-34503	18	8	release	release	VERB
ajbspi-34503	18	9	the	the	DET
ajbspi-34503	18	10	drug	drug	NOUN
ajbspi-34503	18	11	in	in	ADP
ajbspi-34503	18	12	a	a	DET
ajbspi-34503	18	13	sustained	sustained	ADJ
ajbspi-34503	18	14	manner	manner	NOUN
ajbspi-34503	18	15	,	,	PUNCT
ajbspi-34503	18	16	ensuring	ensure	VERB
ajbspi-34503	18	17	prolonged	prolonged	ADJ
ajbspi-34503	18	18	therapeutic	therapeutic	ADJ
ajbspi-34503	18	19	efficacy	efficacy	NOUN
ajbspi-34503	18	20	while	while	SCONJ
ajbspi-34503	18	21	minimizing	minimize	VERB
ajbspi-34503	18	22	systemic	systemic	ADJ
ajbspi-34503	18	23	exposure	exposure	NOUN
ajbspi-34503	18	24	and	and	CCONJ
ajbspi-34503	18	25	side	side	NOUN
ajbspi-34503	18	26	effects	effect	NOUN
ajbspi-34503	18	27	.	.	PUNCT
ajbspi-34503	19	1	additionally	additionally	ADV
ajbspi-34503	19	2	,	,	PUNCT
ajbspi-34503	19	3	nanoparticles	nanoparticle	NOUN
ajbspi-34503	19	4	can	can	AUX
ajbspi-34503	19	5	be	be	AUX
ajbspi-34503	19	6	functionalized	functionalize	VERB
ajbspi-34503	19	7	to	to	PART
ajbspi-34503	19	8	target	target	VERB
ajbspi-34503	19	9	specific	specific	ADJ
ajbspi-34503	19	10	fungal	fungal	ADJ
ajbspi-34503	19	11	species	specie	NOUN
ajbspi-34503	19	12	or	or	CCONJ
ajbspi-34503	19	13	biofilms	biofilm	NOUN
ajbspi-34503	19	14	,	,	PUNCT
ajbspi-34503	19	15	further	far	ADV
ajbspi-34503	19	16	enhancing	enhance	VERB
ajbspi-34503	19	17	the	the	DET
ajbspi-34503	19	18	therapeutic	therapeutic	ADJ
ajbspi-34503	19	19	outcome	outcome	NOUN
ajbspi-34503	19	20	.	.	PUNCT
ajbspi-34503	20	1	the	the	DET
ajbspi-34503	20	2	development	development	NOUN
ajbspi-34503	20	3	of	of	ADP
ajbspi-34503	20	4	the	the	DET
ajbspi-34503	20	5	nanoparticle	nanoparticle	NOUN
ajbspi-34503	20	6	-	-	PUNCT
ajbspi-34503	20	7	based	base	VERB
ajbspi-34503	20	8	topical	topical	ADJ
ajbspi-34503	20	9	gel	gel	NOUN
ajbspi-34503	20	10	involves	involve	VERB
ajbspi-34503	20	11	several	several	ADJ
ajbspi-34503	20	12	key	key	ADJ
ajbspi-34503	20	13	steps	step	NOUN
ajbspi-34503	20	14	,	,	PUNCT
ajbspi-34503	20	15	including	include	VERB
ajbspi-34503	20	16	the	the	DET
ajbspi-34503	20	17	selection	selection	NOUN
ajbspi-34503	20	18	of	of	ADP
ajbspi-34503	20	19	biocompatible	biocompatible	ADJ
ajbspi-34503	20	20	and	and	CCONJ
ajbspi-34503	20	21	biodegradable	biodegradable	ADJ
ajbspi-34503	20	22	materials	material	NOUN
ajbspi-34503	20	23	for	for	ADP
ajbspi-34503	20	24	nanoparticle	nanoparticle	NOUN
ajbspi-34503	20	25	synthesis	synthesis	NOUN
ajbspi-34503	20	26	,	,	PUNCT
ajbspi-34503	20	27	optimization	optimization	NOUN
ajbspi-34503	20	28	of	of	ADP
ajbspi-34503	20	29	drug	drug	NOUN
ajbspi-34503	20	30	loading	loading	NOUN
ajbspi-34503	20	31	and	and	CCONJ
ajbspi-34503	20	32	release	release	NOUN
ajbspi-34503	20	33	kinetics	kinetic	NOUN
ajbspi-34503	20	34	,	,	PUNCT
ajbspi-34503	20	35	and	and	CCONJ
ajbspi-34503	20	36	characterization	characterization	NOUN
ajbspi-34503	20	37	of	of	ADP
ajbspi-34503	20	38	physicochemical	physicochemical	ADJ
ajbspi-34503	20	39	properties	property	NOUN
ajbspi-34503	20	40	.	.	PUNCT
ajbspi-34503	21	1	furthermore	furthermore	ADV
ajbspi-34503	21	2	,	,	PUNCT
ajbspi-34503	21	3	in	in	ADP
ajbspi-34503	21	4	vitro	vitro	X
ajbspi-34503	21	5	and	and	CCONJ
ajbspi-34503	21	6	in	in	ADP
ajbspi-34503	21	7	vivo	vivo	ADJ
ajbspi-34503	21	8	evaluations	evaluation	NOUN
ajbspi-34503	21	9	are	be	AUX
ajbspi-34503	21	10	conducted	conduct	VERB
ajbspi-34503	21	11	to	to	PART
ajbspi-34503	21	12	assess	assess	VERB
ajbspi-34503	21	13	the	the	DET
ajbspi-34503	21	14	antifungal	antifungal	ADJ
ajbspi-34503	21	15	activity	activity	NOUN
ajbspi-34503	21	16	,	,	PUNCT
ajbspi-34503	21	17	skin	skin	NOUN
ajbspi-34503	21	18	permeation	permeation	NOUN
ajbspi-34503	21	19	profile	profile	NOUN
ajbspi-34503	21	20	,	,	PUNCT
ajbspi-34503	21	21	and	and	CCONJ
ajbspi-34503	21	22	safety	safety	NOUN
ajbspi-34503	21	23	profile	profile	NOUN
ajbspi-34503	21	24	of	of	ADP
ajbspi-34503	21	25	the	the	DET
ajbspi-34503	21	26	nanoformulation	nanoformulation	NOUN
ajbspi-34503	21	27	.	.	PUNCT
ajbspi-34503	22	1	by	by	ADP
ajbspi-34503	22	2	leveraging	leverage	VERB
ajbspi-34503	22	3	the	the	DET
ajbspi-34503	22	4	advantages	advantage	NOUN
ajbspi-34503	22	5	of	of	ADP
ajbspi-34503	22	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	22	7	-	-	PUNCT
ajbspi-34503	22	8	based	base	VERB
ajbspi-34503	22	9	drug	drug	NOUN
ajbspi-34503	22	10	delivery	delivery	NOUN
ajbspi-34503	22	11	systems	system	NOUN
ajbspi-34503	22	12	,	,	PUNCT
ajbspi-34503	22	13	this	this	DET
ajbspi-34503	22	14	study	study	NOUN
ajbspi-34503	22	15	aims	aim	VERB
ajbspi-34503	22	16	to	to	PART
ajbspi-34503	22	17	provide	provide	VERB
ajbspi-34503	22	18	a	a	DET
ajbspi-34503	22	19	comprehensive	comprehensive	ADJ
ajbspi-34503	22	20	understanding	understanding	NOUN
ajbspi-34503	22	21	of	of	ADP
ajbspi-34503	22	22	the	the	DET
ajbspi-34503	22	23	potential	potential	NOUN
ajbspi-34503	22	24	of	of	ADP
ajbspi-34503	22	25	the	the	DET
ajbspi-34503	22	26	nanoparticle	nanoparticle	NOUN
ajbspi-34503	22	27	-	-	PUNCT
ajbspi-34503	22	28	based	base	VERB
ajbspi-34503	22	29	topical	topical	ADJ
ajbspi-34503	22	30	gel	gel	NOUN
ajbspi-34503	22	31	containing	contain	VERB
ajbspi-34503	22	32	fluconazole	fluconazole	NOUN
ajbspi-34503	22	33	as	as	ADP
ajbspi-34503	22	34	a	a	DET
ajbspi-34503	22	35	promising	promising	ADJ
ajbspi-34503	22	36	antifungal	antifungal	ADJ
ajbspi-34503	22	37	treatment	treatment	NOUN
ajbspi-34503	22	38	.	.	PUNCT
ajbspi-34503	23	1	the	the	DET
ajbspi-34503	23	2	findings	finding	NOUN
ajbspi-34503	23	3	of	of	ADP
ajbspi-34503	23	4	this	this	DET
ajbspi-34503	23	5	research	research	NOUN
ajbspi-34503	23	6	have	have	VERB
ajbspi-34503	23	7	the	the	DET
ajbspi-34503	23	8	potential	potential	NOUN
ajbspi-34503	23	9	to	to	PART
ajbspi-34503	23	10	inform	inform	VERB
ajbspi-34503	23	11	the	the	DET
ajbspi-34503	23	12	development	development	NOUN
ajbspi-34503	23	13	of	of	ADP
ajbspi-34503	23	14	innovative	innovative	ADJ
ajbspi-34503	23	15	therapies	therapy	NOUN
ajbspi-34503	23	16	for	for	ADP
ajbspi-34503	23	17	the	the	DET
ajbspi-34503	23	18	management	management	NOUN
ajbspi-34503	23	19	of	of	ADP
ajbspi-34503	23	20	fungal	fungal	ADJ
ajbspi-34503	23	21	infections	infection	NOUN
ajbspi-34503	23	22	,	,	PUNCT
ajbspi-34503	23	23	addressing	address	VERB
ajbspi-34503	23	24	the	the	DET
ajbspi-34503	23	25	unmet	unmet	NOUN
ajbspi-34503	23	26	clinical	clinical	ADJ
ajbspi-34503	23	27	needs	need	NOUN
ajbspi-34503	23	28	and	and	CCONJ
ajbspi-34503	23	29	improving	improve	VERB
ajbspi-34503	23	30	patient	patient	ADJ
ajbspi-34503	23	31	outcomes	outcome	NOUN
ajbspi-34503	23	32	in	in	ADP
ajbspi-34503	23	33	dermatology	dermatology	NOUN
ajbspi-34503	23	34	and	and	CCONJ
ajbspi-34503	23	35	beyond	beyond	ADP
ajbspi-34503	23	36	.	.	PUNCT
ajbspi-34503	24	1	method	method	VERB
ajbspi-34503	24	2	the	the	DET
ajbspi-34503	24	3	process	process	NOUN
ajbspi-34503	24	4	of	of	ADP
ajbspi-34503	24	5	formulating	formulate	VERB
ajbspi-34503	24	6	and	and	CCONJ
ajbspi-34503	24	7	evaluating	evaluate	VERB
ajbspi-34503	24	8	the	the	DET
ajbspi-34503	24	9	nanoparticle	nanoparticle	NOUN
ajbspi-34503	24	10	-	-	PUNCT
ajbspi-34503	24	11	based	base	VERB
ajbspi-34503	24	12	topical	topical	ADJ
ajbspi-34503	24	13	gel	gel	NOUN
ajbspi-34503	24	14	containing	contain	VERB
ajbspi-34503	24	15	fluconazole	fluconazole	NOUN
ajbspi-34503	24	16	involves	involve	VERB
ajbspi-34503	24	17	several	several	ADJ
ajbspi-34503	24	18	sequential	sequential	ADJ
ajbspi-34503	24	19	steps	step	NOUN
ajbspi-34503	24	20	aimed	aim	VERB
ajbspi-34503	24	21	at	at	ADP
ajbspi-34503	24	22	optimizing	optimize	VERB
ajbspi-34503	24	23	drug	drug	NOUN
ajbspi-34503	24	24	delivery	delivery	NOUN
ajbspi-34503	24	25	and	and	CCONJ
ajbspi-34503	24	26	assessing	assess	VERB
ajbspi-34503	24	27	its	its	PRON
ajbspi-34503	24	28	efficacy	efficacy	NOUN
ajbspi-34503	24	29	as	as	ADP
ajbspi-34503	24	30	an	an	DET
ajbspi-34503	24	31	antifungal	antifungal	ADJ
ajbspi-34503	24	32	treatment	treatment	NOUN
ajbspi-34503	24	33	.	.	PUNCT
ajbspi-34503	25	1	initially	initially	ADV
ajbspi-34503	25	2	,	,	PUNCT
ajbspi-34503	25	3	nanoparticles	nanoparticle	NOUN
ajbspi-34503	25	4	are	be	AUX
ajbspi-34503	25	5	synthesized	synthesize	VERB
ajbspi-34503	25	6	using	use	VERB
ajbspi-34503	25	7	biocompatible	biocompatible	ADJ
ajbspi-34503	25	8	and	and	CCONJ
ajbspi-34503	25	9	biodegradable	biodegradable	ADJ
ajbspi-34503	25	10	polymers	polymer	NOUN
ajbspi-34503	25	11	through	through	ADP
ajbspi-34503	25	12	established	establish	VERB
ajbspi-34503	25	13	techniques	technique	NOUN
ajbspi-34503	25	14	such	such	ADJ
ajbspi-34503	25	15	as	as	ADP
ajbspi-34503	25	16	nanoprecipitation	nanoprecipitation	NOUN
ajbspi-34503	25	17	or	or	CCONJ
ajbspi-34503	25	18	emulsion	emulsion	NOUN
ajbspi-34503	25	19	methods	method	NOUN
ajbspi-34503	25	20	.	.	PUNCT
ajbspi-34503	26	1	these	these	DET
ajbspi-34503	26	2	nanoparticles	nanoparticle	NOUN
ajbspi-34503	26	3	are	be	AUX
ajbspi-34503	26	4	characterized	characterize	VERB
ajbspi-34503	26	5	extensively	extensively	ADV
ajbspi-34503	26	6	for	for	ADP
ajbspi-34503	26	7	size	size	NOUN
ajbspi-34503	26	8	,	,	PUNCT
ajbspi-34503	26	9	morphology	morphology	NOUN
ajbspi-34503	26	10	,	,	PUNCT
ajbspi-34503	26	11	surface	surface	NOUN
ajbspi-34503	26	12	charge	charge	NOUN
ajbspi-34503	26	13	,	,	PUNCT
ajbspi-34503	26	14	and	and	CCONJ
ajbspi-34503	26	15	drug	drug	NOUN
ajbspi-34503	26	16	loading	loading	NOUN
ajbspi-34503	26	17	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34503	26	18	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	26	19	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	26	20	volume	volume	NOUN
ajbspi-34503	26	21	04	04	NUM
ajbspi-34503	26	22	issue	issue	NOUN
ajbspi-34503	26	23	03	03	NUM
ajbspi-34503	26	24	-	-	SYM
ajbspi-34503	26	25	2024	2024	NUM
ajbspi-34503	26	26	11	11	NUM
ajbspi-34503	26	27	american	american	ADJ
ajbspi-34503	26	28	journal	journal	PROPN
ajbspi-34503	26	29	of	of	ADP
ajbspi-34503	26	30	biomedical	biomedical	PROPN
ajbspi-34503	26	31	science	science	PROPN
ajbspi-34503	26	32	&	&	CCONJ
ajbspi-34503	26	33	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	26	34	innovation	innovation	NOUN
ajbspi-34503	26	35	(	(	PUNCT
ajbspi-34503	26	36	issn	issn	PROPN
ajbspi-34503	26	37	–	–	PUNCT
ajbspi-34503	26	38	2771	2771	NUM
ajbspi-34503	26	39	-	-	SYM
ajbspi-34503	26	40	2753	2753	NUM
ajbspi-34503	26	41	)	)	PUNCT
ajbspi-34503	26	42	volume	volume	NOUN
ajbspi-34503	26	43	04	04	NUM
ajbspi-34503	26	44	issue	issue	NOUN
ajbspi-34503	26	45	03	03	NUM
ajbspi-34503	26	46	pages	page	NOUN
ajbspi-34503	26	47	:	:	PUNCT
ajbspi-34503	26	48	9	9	NUM
ajbspi-34503	26	49	-	-	SYM
ajbspi-34503	26	50	17	17	NUM
ajbspi-34503	26	51	sjif	sjif	NOUN
ajbspi-34503	26	52	impact	impact	NOUN
ajbspi-34503	26	53	factor	factor	NOUN
ajbspi-34503	26	54	(	(	PUNCT
ajbspi-34503	26	55	2021	2021	NUM
ajbspi-34503	26	56	:	:	PUNCT
ajbspi-34503	26	57	5	5	NUM
ajbspi-34503	26	58	.	.	NOUN
ajbspi-34503	26	59	705	705	NUM
ajbspi-34503	26	60	)	)	PUNCT
ajbspi-34503	26	61	(	(	PUNCT
ajbspi-34503	26	62	2022	2022	NUM
ajbspi-34503	26	63	:	:	PUNCT
ajbspi-34503	26	64	5	5	NUM
ajbspi-34503	26	65	.	.	NOUN
ajbspi-34503	26	66	705	705	NUM
ajbspi-34503	26	67	)	)	PUNCT
ajbspi-34503	26	68	(	(	PUNCT
ajbspi-34503	26	69	2023	2023	NUM
ajbspi-34503	26	70	:	:	PUNCT
ajbspi-34503	26	71	6.534	6.534	NUM
ajbspi-34503	26	72	)	)	PUNCT
ajbspi-34503	26	73	oclc	oclc	PROPN
ajbspi-34503	26	74	–	–	PUNCT
ajbspi-34503	26	75	1121105677	1121105677	NUM
ajbspi-34503	26	76	publisher	publisher	NOUN
ajbspi-34503	26	77	:	:	PUNCT
ajbspi-34503	26	78	oscar	oscar	NOUN
ajbspi-34503	26	79	publishing	publishing	NOUN
ajbspi-34503	26	80	services	service	NOUN
ajbspi-34503	26	81	servi	servi	ADJ
ajbspi-34503	26	82	efficiency	efficiency	NOUN
ajbspi-34503	26	83	using	use	VERB
ajbspi-34503	26	84	techniques	technique	NOUN
ajbspi-34503	26	85	like	like	ADP
ajbspi-34503	26	86	dynamic	dynamic	ADJ
ajbspi-34503	26	87	light	light	NOUN
ajbspi-34503	26	88	scattering	scattering	NOUN
ajbspi-34503	26	89	(	(	PUNCT
ajbspi-34503	26	90	dls	dls	PROPN
ajbspi-34503	26	91	)	)	PUNCT
ajbspi-34503	26	92	and	and	CCONJ
ajbspi-34503	26	93	electron	electron	NOUN
ajbspi-34503	26	94	microscopy	microscopy	NOUN
ajbspi-34503	26	95	.	.	PUNCT
ajbspi-34503	27	1	following	follow	VERB
ajbspi-34503	27	2	nanoparticle	nanoparticle	NOUN
ajbspi-34503	27	3	synthesis	synthesis	NOUN
ajbspi-34503	27	4	,	,	PUNCT
ajbspi-34503	27	5	the	the	DET
ajbspi-34503	27	6	formulation	formulation	NOUN
ajbspi-34503	27	7	of	of	ADP
ajbspi-34503	27	8	the	the	DET
ajbspi-34503	27	9	topical	topical	ADJ
ajbspi-34503	27	10	gel	gel	NOUN
ajbspi-34503	27	11	begins	begin	VERB
ajbspi-34503	27	12	by	by	ADP
ajbspi-34503	27	13	selecting	select	VERB
ajbspi-34503	27	14	a	a	DET
ajbspi-34503	27	15	suitable	suitable	ADJ
ajbspi-34503	27	16	gel	gel	NOUN
ajbspi-34503	27	17	base	base	NOUN
ajbspi-34503	27	18	,	,	PUNCT
ajbspi-34503	27	19	typically	typically	ADV
ajbspi-34503	27	20	carbomer	carbomer	NOUN
ajbspi-34503	27	21	or	or	CCONJ
ajbspi-34503	27	22	hydroxypropyl	hydroxypropyl	ADJ
ajbspi-34503	27	23	methylcellulose	methylcellulose	NOUN
ajbspi-34503	27	24	(	(	PUNCT
ajbspi-34503	27	25	hpmc	hpmc	ADJ
ajbspi-34503	27	26	)	)	PUNCT
ajbspi-34503	27	27	,	,	PUNCT
ajbspi-34503	27	28	that	that	PRON
ajbspi-34503	27	29	can	can	AUX
ajbspi-34503	27	30	accommodate	accommodate	VERB
ajbspi-34503	27	31	the	the	DET
ajbspi-34503	27	32	nanoparticles	nanoparticle	NOUN
ajbspi-34503	27	33	.	.	PUNCT
ajbspi-34503	28	1	the	the	DET
ajbspi-34503	28	2	nanoparticles	nanoparticle	NOUN
ajbspi-34503	28	3	are	be	AUX
ajbspi-34503	28	4	then	then	ADV
ajbspi-34503	28	5	incorporated	incorporate	VERB
ajbspi-34503	28	6	into	into	ADP
ajbspi-34503	28	7	the	the	DET
ajbspi-34503	28	8	gel	gel	NOUN
ajbspi-34503	28	9	matrix	matrix	NOUN
ajbspi-34503	28	10	using	use	VERB
ajbspi-34503	28	11	appropriate	appropriate	ADJ
ajbspi-34503	28	12	dispersion	dispersion	NOUN
ajbspi-34503	28	13	techniques	technique	NOUN
ajbspi-34503	28	14	to	to	PART
ajbspi-34503	28	15	ensure	ensure	VERB
ajbspi-34503	28	16	homogeneity	homogeneity	NOUN
ajbspi-34503	28	17	.	.	PUNCT
ajbspi-34503	29	1	the	the	DET
ajbspi-34503	29	2	formulation	formulation	NOUN
ajbspi-34503	29	3	parameters	parameter	NOUN
ajbspi-34503	29	4	,	,	PUNCT
ajbspi-34503	29	5	including	include	VERB
ajbspi-34503	29	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	29	7	concentration	concentration	NOUN
ajbspi-34503	29	8	,	,	PUNCT
ajbspi-34503	29	9	viscosity	viscosity	NOUN
ajbspi-34503	29	10	,	,	PUNCT
ajbspi-34503	29	11	ph	ph	VERB
ajbspi-34503	29	12	,	,	PUNCT
ajbspi-34503	29	13	and	and	CCONJ
ajbspi-34503	29	14	stability	stability	NOUN
ajbspi-34503	29	15	,	,	PUNCT
ajbspi-34503	29	16	are	be	AUX
ajbspi-34503	29	17	optimized	optimize	VERB
ajbspi-34503	29	18	to	to	PART
ajbspi-34503	29	19	achieve	achieve	VERB
ajbspi-34503	29	20	desired	desire	VERB
ajbspi-34503	29	21	rheological	rheological	ADJ
ajbspi-34503	29	22	properties	property	NOUN
ajbspi-34503	29	23	and	and	CCONJ
ajbspi-34503	29	24	drug	drug	NOUN
ajbspi-34503	29	25	release	release	NOUN
ajbspi-34503	29	26	kinetics	kinetic	NOUN
ajbspi-34503	29	27	.	.	PUNCT
ajbspi-34503	30	1	subsequently	subsequently	ADV
ajbspi-34503	30	2	,	,	PUNCT
ajbspi-34503	30	3	in	in	ADP
ajbspi-34503	30	4	vitro	vitro	X
ajbspi-34503	30	5	drug	drug	NOUN
ajbspi-34503	30	6	release	release	NOUN
ajbspi-34503	30	7	studies	study	NOUN
ajbspi-34503	30	8	are	be	AUX
ajbspi-34503	30	9	conducted	conduct	VERB
ajbspi-34503	30	10	to	to	PART
ajbspi-34503	30	11	assess	assess	VERB
ajbspi-34503	30	12	the	the	DET
ajbspi-34503	30	13	release	release	NOUN
ajbspi-34503	30	14	profile	profile	NOUN
ajbspi-34503	30	15	of	of	ADP
ajbspi-34503	30	16	fluconazole	fluconazole	NOUN
ajbspi-34503	30	17	from	from	ADP
ajbspi-34503	30	18	the	the	DET
ajbspi-34503	30	19	nanoparticle	nanoparticle	NOUN
ajbspi-34503	30	20	-	-	PUNCT
ajbspi-34503	30	21	based	base	VERB
ajbspi-34503	30	22	topical	topical	ADJ
ajbspi-34503	30	23	gel	gel	NOUN
ajbspi-34503	30	24	.	.	PUNCT
ajbspi-34503	31	1	these	these	DET
ajbspi-34503	31	2	studies	study	NOUN
ajbspi-34503	31	3	typically	typically	ADV
ajbspi-34503	31	4	employ	employ	VERB
ajbspi-34503	31	5	standard	standard	ADJ
ajbspi-34503	31	6	dialysis	dialysis	NOUN
ajbspi-34503	31	7	membrane	membrane	NOUN
ajbspi-34503	31	8	or	or	CCONJ
ajbspi-34503	31	9	franz	franz	NOUN
ajbspi-34503	31	10	diffusion	diffusion	NOUN
ajbspi-34503	31	11	cell	cell	NOUN
ajbspi-34503	31	12	methods	method	NOUN
ajbspi-34503	31	13	to	to	PART
ajbspi-34503	31	14	monitor	monitor	VERB
ajbspi-34503	31	15	drug	drug	NOUN
ajbspi-34503	31	16	release	release	NOUN
ajbspi-34503	31	17	over	over	ADP
ajbspi-34503	31	18	time	time	NOUN
ajbspi-34503	31	19	.	.	PUNCT
ajbspi-34503	32	1	samples	sample	NOUN
ajbspi-34503	32	2	are	be	AUX
ajbspi-34503	32	3	collected	collect	VERB
ajbspi-34503	32	4	at	at	ADP
ajbspi-34503	32	5	predetermined	predetermine	VERB
ajbspi-34503	32	6	intervals	interval	NOUN
ajbspi-34503	32	7	,	,	PUNCT
ajbspi-34503	32	8	and	and	CCONJ
ajbspi-34503	32	9	the	the	DET
ajbspi-34503	32	10	amount	amount	NOUN
ajbspi-34503	32	11	of	of	ADP
ajbspi-34503	32	12	drug	drug	NOUN
ajbspi-34503	32	13	released	release	VERB
ajbspi-34503	32	14	is	be	AUX
ajbspi-34503	32	15	quantified	quantify	VERB
ajbspi-34503	32	16	using	use	VERB
ajbspi-34503	32	17	validated	validate	VERB
ajbspi-34503	32	18	analytical	analytical	ADJ
ajbspi-34503	32	19	techniques	technique	NOUN
ajbspi-34503	32	20	such	such	ADJ
ajbspi-34503	32	21	as	as	ADP
ajbspi-34503	32	22	highperformance	highperformance	NOUN
ajbspi-34503	32	23	liquid	liquid	ADJ
ajbspi-34503	32	24	chromatography	chromatography	NOUN
ajbspi-34503	32	25	(	(	PUNCT
ajbspi-34503	32	26	hplc	hplc	NOUN
ajbspi-34503	32	27	)	)	PUNCT
ajbspi-34503	32	28	or	or	CCONJ
ajbspi-34503	32	29	uvvisible	uvvisible	ADJ
ajbspi-34503	32	30	spectrophotometry	spectrophotometry	NOUN
ajbspi-34503	32	31	.	.	PUNCT
ajbspi-34503	33	1	the	the	DET
ajbspi-34503	33	2	antifungal	antifungal	ADJ
ajbspi-34503	33	3	activity	activity	NOUN
ajbspi-34503	33	4	of	of	ADP
ajbspi-34503	33	5	the	the	DET
ajbspi-34503	33	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	33	7	-	-	PUNCT
ajbspi-34503	33	8	based	base	VERB
ajbspi-34503	33	9	topical	topical	ADJ
ajbspi-34503	33	10	gel	gel	NOUN
ajbspi-34503	33	11	is	be	AUX
ajbspi-34503	33	12	then	then	ADV
ajbspi-34503	33	13	evaluated	evaluate	VERB
ajbspi-34503	33	14	using	use	VERB
ajbspi-34503	33	15	standard	standard	ADJ
ajbspi-34503	33	16	susceptibility	susceptibility	NOUN
ajbspi-34503	33	17	testing	testing	NOUN
ajbspi-34503	33	18	methods	method	NOUN
ajbspi-34503	33	19	against	against	ADP
ajbspi-34503	33	20	clinically	clinically	ADV
ajbspi-34503	33	21	relevant	relevant	ADJ
ajbspi-34503	33	22	fungal	fungal	ADJ
ajbspi-34503	33	23	strains	strain	NOUN
ajbspi-34503	33	24	.	.	PUNCT
ajbspi-34503	34	1	minimum	minimum	ADJ
ajbspi-34503	34	2	inhibitory	inhibitory	ADJ
ajbspi-34503	34	3	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34503	34	4	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	34	5	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	34	6	volume	volume	NOUN
ajbspi-34503	34	7	04	04	NUM
ajbspi-34503	34	8	issue	issue	NOUN
ajbspi-34503	34	9	03	03	NUM
ajbspi-34503	34	10	-	-	SYM
ajbspi-34503	34	11	2024	2024	NUM
ajbspi-34503	34	12	12	12	NUM
ajbspi-34503	34	13	american	american	ADJ
ajbspi-34503	34	14	journal	journal	PROPN
ajbspi-34503	34	15	of	of	ADP
ajbspi-34503	34	16	biomedical	biomedical	PROPN
ajbspi-34503	34	17	science	science	PROPN
ajbspi-34503	34	18	&	&	CCONJ
ajbspi-34503	34	19	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	34	20	innovation	innovation	NOUN
ajbspi-34503	34	21	(	(	PUNCT
ajbspi-34503	34	22	issn	issn	PROPN
ajbspi-34503	34	23	–	–	PUNCT
ajbspi-34503	34	24	2771	2771	NUM
ajbspi-34503	34	25	-	-	SYM
ajbspi-34503	34	26	2753	2753	NUM
ajbspi-34503	34	27	)	)	PUNCT
ajbspi-34503	34	28	volume	volume	NOUN
ajbspi-34503	34	29	04	04	NUM
ajbspi-34503	34	30	issue	issue	NOUN
ajbspi-34503	34	31	03	03	NUM
ajbspi-34503	34	32	pages	page	NOUN
ajbspi-34503	34	33	:	:	PUNCT
ajbspi-34503	34	34	9	9	NUM
ajbspi-34503	34	35	-	-	SYM
ajbspi-34503	34	36	17	17	NUM
ajbspi-34503	34	37	sjif	sjif	NOUN
ajbspi-34503	34	38	impact	impact	NOUN
ajbspi-34503	34	39	factor	factor	NOUN
ajbspi-34503	34	40	(	(	PUNCT
ajbspi-34503	34	41	2021	2021	NUM
ajbspi-34503	34	42	:	:	PUNCT
ajbspi-34503	34	43	5	5	NUM
ajbspi-34503	34	44	.	.	NOUN
ajbspi-34503	34	45	705	705	NUM
ajbspi-34503	34	46	)	)	PUNCT
ajbspi-34503	34	47	(	(	PUNCT
ajbspi-34503	34	48	2022	2022	NUM
ajbspi-34503	34	49	:	:	PUNCT
ajbspi-34503	34	50	5	5	NUM
ajbspi-34503	34	51	.	.	NOUN
ajbspi-34503	34	52	705	705	NUM
ajbspi-34503	34	53	)	)	PUNCT
ajbspi-34503	34	54	(	(	PUNCT
ajbspi-34503	34	55	2023	2023	NUM
ajbspi-34503	34	56	:	:	PUNCT
ajbspi-34503	34	57	6.534	6.534	NUM
ajbspi-34503	34	58	)	)	PUNCT
ajbspi-34503	34	59	oclc	oclc	PROPN
ajbspi-34503	34	60	–	–	PUNCT
ajbspi-34503	34	61	1121105677	1121105677	NUM
ajbspi-34503	34	62	publisher	publisher	NOUN
ajbspi-34503	34	63	:	:	PUNCT
ajbspi-34503	34	64	oscar	oscar	NOUN
ajbspi-34503	34	65	publishing	publishing	NOUN
ajbspi-34503	34	66	services	service	NOUN
ajbspi-34503	34	67	servi	servi	ADJ
ajbspi-34503	34	68	concentration	concentration	NOUN
ajbspi-34503	34	69	(	(	PUNCT
ajbspi-34503	34	70	mic	mic	ADJ
ajbspi-34503	34	71	)	)	PUNCT
ajbspi-34503	34	72	or	or	CCONJ
ajbspi-34503	34	73	minimum	minimum	ADJ
ajbspi-34503	34	74	fungicidal	fungicidal	ADJ
ajbspi-34503	34	75	concentration	concentration	NOUN
ajbspi-34503	34	76	(	(	PUNCT
ajbspi-34503	34	77	mfc	mfc	NOUN
ajbspi-34503	34	78	)	)	PUNCT
ajbspi-34503	34	79	assays	assay	NOUN
ajbspi-34503	34	80	are	be	AUX
ajbspi-34503	34	81	performed	perform	VERB
ajbspi-34503	34	82	to	to	PART
ajbspi-34503	34	83	determine	determine	VERB
ajbspi-34503	34	84	the	the	DET
ajbspi-34503	34	85	effectiveness	effectiveness	NOUN
ajbspi-34503	34	86	of	of	ADP
ajbspi-34503	34	87	the	the	DET
ajbspi-34503	34	88	gel	gel	NOUN
ajbspi-34503	34	89	formulation	formulation	NOUN
ajbspi-34503	34	90	in	in	ADP
ajbspi-34503	34	91	inhibiting	inhibit	VERB
ajbspi-34503	34	92	fungal	fungal	ADJ
ajbspi-34503	34	93	growth	growth	NOUN
ajbspi-34503	34	94	compared	compare	VERB
ajbspi-34503	34	95	to	to	ADP
ajbspi-34503	34	96	conventional	conventional	ADJ
ajbspi-34503	34	97	fluconazole	fluconazole	NOUN
ajbspi-34503	34	98	formulations	formulation	NOUN
ajbspi-34503	34	99	.	.	PUNCT
ajbspi-34503	35	1	skin	skin	NOUN
ajbspi-34503	35	2	permeation	permeation	NOUN
ajbspi-34503	35	3	studies	study	NOUN
ajbspi-34503	35	4	are	be	AUX
ajbspi-34503	35	5	conducted	conduct	VERB
ajbspi-34503	35	6	using	use	VERB
ajbspi-34503	35	7	franz	franz	PROPN
ajbspi-34503	35	8	diffusion	diffusion	NOUN
ajbspi-34503	35	9	cells	cell	NOUN
ajbspi-34503	35	10	to	to	PART
ajbspi-34503	35	11	assess	assess	VERB
ajbspi-34503	35	12	the	the	DET
ajbspi-34503	35	13	permeation	permeation	NOUN
ajbspi-34503	35	14	profile	profile	NOUN
ajbspi-34503	35	15	of	of	ADP
ajbspi-34503	35	16	fluconazole	fluconazole	NOUN
ajbspi-34503	35	17	from	from	ADP
ajbspi-34503	35	18	the	the	DET
ajbspi-34503	35	19	gel	gel	NOUN
ajbspi-34503	35	20	across	across	ADP
ajbspi-34503	35	21	the	the	DET
ajbspi-34503	35	22	skin	skin	NOUN
ajbspi-34503	35	23	barrier	barrier	NOUN
ajbspi-34503	35	24	.	.	PUNCT
ajbspi-34503	36	1	safety	safety	NOUN
ajbspi-34503	36	2	and	and	CCONJ
ajbspi-34503	36	3	stability	stability	NOUN
ajbspi-34503	36	4	assessments	assessment	NOUN
ajbspi-34503	36	5	are	be	AUX
ajbspi-34503	36	6	carried	carry	VERB
ajbspi-34503	36	7	out	out	ADP
ajbspi-34503	36	8	to	to	PART
ajbspi-34503	36	9	ensure	ensure	VERB
ajbspi-34503	36	10	the	the	DET
ajbspi-34503	36	11	suitability	suitability	NOUN
ajbspi-34503	36	12	of	of	ADP
ajbspi-34503	36	13	the	the	DET
ajbspi-34503	36	14	nanoparticle	nanoparticle	NOUN
ajbspi-34503	36	15	-	-	PUNCT
ajbspi-34503	36	16	based	base	VERB
ajbspi-34503	36	17	topical	topical	ADJ
ajbspi-34503	36	18	gel	gel	NOUN
ajbspi-34503	36	19	for	for	ADP
ajbspi-34503	36	20	clinical	clinical	ADJ
ajbspi-34503	36	21	use	use	NOUN
ajbspi-34503	36	22	.	.	PUNCT
ajbspi-34503	37	1	cytotoxicity	cytotoxicity	NOUN
ajbspi-34503	37	2	assays	assay	NOUN
ajbspi-34503	37	3	using	use	VERB
ajbspi-34503	37	4	appropriate	appropriate	ADJ
ajbspi-34503	37	5	cell	cell	NOUN
ajbspi-34503	37	6	lines	line	NOUN
ajbspi-34503	37	7	and	and	CCONJ
ajbspi-34503	37	8	histological	histological	ADJ
ajbspi-34503	37	9	examination	examination	NOUN
ajbspi-34503	37	10	of	of	ADP
ajbspi-34503	37	11	skin	skin	NOUN
ajbspi-34503	37	12	samples	sample	NOUN
ajbspi-34503	37	13	are	be	AUX
ajbspi-34503	37	14	performed	perform	VERB
ajbspi-34503	37	15	to	to	PART
ajbspi-34503	37	16	evaluate	evaluate	VERB
ajbspi-34503	37	17	the	the	DET
ajbspi-34503	37	18	safety	safety	NOUN
ajbspi-34503	37	19	profile	profile	NOUN
ajbspi-34503	37	20	of	of	ADP
ajbspi-34503	37	21	the	the	DET
ajbspi-34503	37	22	formulation	formulation	NOUN
ajbspi-34503	37	23	.	.	PUNCT
ajbspi-34503	38	1	furthermore	furthermore	ADV
ajbspi-34503	38	2	,	,	PUNCT
ajbspi-34503	38	3	the	the	DET
ajbspi-34503	38	4	physical	physical	ADJ
ajbspi-34503	38	5	and	and	CCONJ
ajbspi-34503	38	6	chemical	chemical	NOUN
ajbspi-34503	38	7	stability	stability	NOUN
ajbspi-34503	38	8	of	of	ADP
ajbspi-34503	38	9	the	the	DET
ajbspi-34503	38	10	gel	gel	NOUN
ajbspi-34503	38	11	formulation	formulation	NOUN
ajbspi-34503	38	12	is	be	AUX
ajbspi-34503	38	13	assessed	assess	VERB
ajbspi-34503	38	14	under	under	ADP
ajbspi-34503	38	15	various	various	ADJ
ajbspi-34503	38	16	storage	storage	NOUN
ajbspi-34503	38	17	conditions	condition	NOUN
ajbspi-34503	38	18	to	to	PART
ajbspi-34503	38	19	ensure	ensure	VERB
ajbspi-34503	38	20	product	product	NOUN
ajbspi-34503	38	21	integrity	integrity	NOUN
ajbspi-34503	38	22	over	over	ADP
ajbspi-34503	38	23	time	time	NOUN
ajbspi-34503	38	24	.	.	PUNCT
ajbspi-34503	39	1	nanoparticle	nanoparticle	NOUN
ajbspi-34503	39	2	synthesis	synthesis	NOUN
ajbspi-34503	39	3	and	and	CCONJ
ajbspi-34503	39	4	characterization	characterization	NOUN
ajbspi-34503	39	5	:	:	PUNCT
ajbspi-34503	39	6	the	the	DET
ajbspi-34503	39	7	nanoparticles	nanoparticle	NOUN
ajbspi-34503	39	8	used	use	VERB
ajbspi-34503	39	9	in	in	ADP
ajbspi-34503	39	10	the	the	DET
ajbspi-34503	39	11	formulation	formulation	NOUN
ajbspi-34503	39	12	were	be	AUX
ajbspi-34503	39	13	synthesized	synthesize	VERB
ajbspi-34503	39	14	using	use	VERB
ajbspi-34503	39	15	a	a	DET
ajbspi-34503	39	16	well	well	ADV
ajbspi-34503	39	17	-	-	PUNCT
ajbspi-34503	39	18	established	establish	VERB
ajbspi-34503	39	19	method	method	NOUN
ajbspi-34503	39	20	based	base	VERB
ajbspi-34503	39	21	on	on	ADP
ajbspi-34503	39	22	the	the	DET
ajbspi-34503	39	23	principles	principle	NOUN
ajbspi-34503	39	24	of	of	ADP
ajbspi-34503	39	25	nanoprecipitation	nanoprecipitation	NOUN
ajbspi-34503	39	26	or	or	CCONJ
ajbspi-34503	39	27	emulsion	emulsion	NOUN
ajbspi-34503	39	28	techniques	technique	NOUN
ajbspi-34503	39	29	.	.	PUNCT
ajbspi-34503	40	1	biocompatible	biocompatible	ADJ
ajbspi-34503	40	2	and	and	CCONJ
ajbspi-34503	40	3	biodegradable	biodegradable	ADJ
ajbspi-34503	40	4	polymers	polymer	NOUN
ajbspi-34503	40	5	,	,	PUNCT
ajbspi-34503	40	6	such	such	ADJ
ajbspi-34503	40	7	as	as	ADP
ajbspi-34503	40	8	poly(lactic	poly(lactic	PROPN
ajbspi-34503	40	9	-	-	PUNCT
ajbspi-34503	40	10	co	co	NOUN
ajbspi-34503	40	11	-	-	ADJ
ajbspi-34503	40	12	glycolic	glycolic	ADJ
ajbspi-34503	40	13	acid	acid	NOUN
ajbspi-34503	40	14	)	)	PUNCT
ajbspi-34503	40	15	(	(	PUNCT
ajbspi-34503	40	16	plga	plga	NOUN
ajbspi-34503	40	17	)	)	PUNCT
ajbspi-34503	40	18	or	or	CCONJ
ajbspi-34503	40	19	chitosan	chitosan	NOUN
ajbspi-34503	40	20	,	,	PUNCT
ajbspi-34503	40	21	were	be	AUX
ajbspi-34503	40	22	selected	select	VERB
ajbspi-34503	40	23	as	as	ADP
ajbspi-34503	40	24	carrier	carrier	NOUN
ajbspi-34503	40	25	materials	material	NOUN
ajbspi-34503	40	26	for	for	ADP
ajbspi-34503	40	27	fluconazole	fluconazole	NOUN
ajbspi-34503	40	28	.	.	PUNCT
ajbspi-34503	41	1	the	the	DET
ajbspi-34503	41	2	nanoparticles	nanoparticle	NOUN
ajbspi-34503	41	3	were	be	AUX
ajbspi-34503	41	4	characterized	characterize	VERB
ajbspi-34503	41	5	for	for	ADP
ajbspi-34503	41	6	their	their	PRON
ajbspi-34503	41	7	size	size	NOUN
ajbspi-34503	41	8	,	,	PUNCT
ajbspi-34503	41	9	morphology	morphology	NOUN
ajbspi-34503	41	10	,	,	PUNCT
ajbspi-34503	41	11	surface	surface	NOUN
ajbspi-34503	41	12	charge	charge	NOUN
ajbspi-34503	41	13	,	,	PUNCT
ajbspi-34503	41	14	and	and	CCONJ
ajbspi-34503	41	15	drug	drug	NOUN
ajbspi-34503	41	16	loading	loading	NOUN
ajbspi-34503	41	17	efficiency	efficiency	NOUN
ajbspi-34503	41	18	using	use	VERB
ajbspi-34503	41	19	techniques	technique	NOUN
ajbspi-34503	41	20	such	such	ADJ
ajbspi-34503	41	21	as	as	ADP
ajbspi-34503	41	22	dynamic	dynamic	ADJ
ajbspi-34503	41	23	light	light	NOUN
ajbspi-34503	41	24	scattering	scattering	NOUN
ajbspi-34503	41	25	(	(	PUNCT
ajbspi-34503	41	26	dls	dls	PROPN
ajbspi-34503	41	27	)	)	PUNCT
ajbspi-34503	41	28	,	,	PUNCT
ajbspi-34503	41	29	transmission	transmission	NOUN
ajbspi-34503	41	30	electron	electron	NOUN
ajbspi-34503	41	31	microscopy	microscopy	NOUN
ajbspi-34503	41	32	(	(	PUNCT
ajbspi-34503	41	33	tem	tem	PROPN
ajbspi-34503	41	34	)	)	PUNCT
ajbspi-34503	41	35	,	,	PUNCT
ajbspi-34503	41	36	scanning	scan	VERB
ajbspi-34503	41	37	electron	electron	NOUN
ajbspi-34503	41	38	microscopy	microscopy	NOUN
ajbspi-34503	41	39	(	(	PUNCT
ajbspi-34503	41	40	sem	sem	NOUN
ajbspi-34503	41	41	)	)	PUNCT
ajbspi-34503	41	42	,	,	PUNCT
ajbspi-34503	41	43	and	and	CCONJ
ajbspi-34503	41	44	fourier	fourier	NOUN
ajbspi-34503	41	45	-	-	PUNCT
ajbspi-34503	41	46	transform	transform	NOUN
ajbspi-34503	41	47	infrared	infrared	ADJ
ajbspi-34503	41	48	spectroscopy	spectroscopy	NOUN
ajbspi-34503	41	49	(	(	PUNCT
ajbspi-34503	41	50	ftir	ftir	PROPN
ajbspi-34503	41	51	)	)	PUNCT
ajbspi-34503	41	52	.	.	PUNCT
ajbspi-34503	42	1	formulation	formulation	NOUN
ajbspi-34503	42	2	of	of	ADP
ajbspi-34503	42	3	topical	topical	ADJ
ajbspi-34503	42	4	gel	gel	NOUN
ajbspi-34503	42	5	:	:	PUNCT
ajbspi-34503	42	6	the	the	DET
ajbspi-34503	42	7	nanoparticle	nanoparticle	NOUN
ajbspi-34503	42	8	-	-	PUNCT
ajbspi-34503	42	9	based	base	VERB
ajbspi-34503	42	10	topical	topical	ADJ
ajbspi-34503	42	11	gel	gel	NOUN
ajbspi-34503	42	12	containing	contain	VERB
ajbspi-34503	42	13	fluconazole	fluconazole	NOUN
ajbspi-34503	42	14	was	be	AUX
ajbspi-34503	42	15	formulated	formulate	VERB
ajbspi-34503	42	16	using	use	VERB
ajbspi-34503	42	17	a	a	DET
ajbspi-34503	42	18	suitable	suitable	ADJ
ajbspi-34503	42	19	gel	gel	NOUN
ajbspi-34503	42	20	base	base	NOUN
ajbspi-34503	42	21	,	,	PUNCT
ajbspi-34503	42	22	such	such	ADJ
ajbspi-34503	42	23	as	as	ADP
ajbspi-34503	42	24	carbomer	carbomer	NOUN
ajbspi-34503	42	25	or	or	CCONJ
ajbspi-34503	42	26	hydroxypropyl	hydroxypropyl	ADJ
ajbspi-34503	42	27	methylcellulose	methylcellulose	NOUN
ajbspi-34503	42	28	(	(	PUNCT
ajbspi-34503	42	29	hpmc	hpmc	ADJ
ajbspi-34503	42	30	)	)	PUNCT
ajbspi-34503	42	31	.	.	PUNCT
ajbspi-34503	43	1	the	the	DET
ajbspi-34503	43	2	synthesized	synthesize	VERB
ajbspi-34503	43	3	nanoparticles	nanoparticle	NOUN
ajbspi-34503	43	4	were	be	AUX
ajbspi-34503	43	5	incorporated	incorporate	VERB
ajbspi-34503	43	6	into	into	ADP
ajbspi-34503	43	7	the	the	DET
ajbspi-34503	43	8	gel	gel	NOUN
ajbspi-34503	43	9	matrix	matrix	NOUN
ajbspi-34503	43	10	using	use	VERB
ajbspi-34503	43	11	appropriate	appropriate	ADJ
ajbspi-34503	43	12	dispersion	dispersion	NOUN
ajbspi-34503	43	13	techniques	technique	NOUN
ajbspi-34503	43	14	to	to	PART
ajbspi-34503	43	15	ensure	ensure	VERB
ajbspi-34503	43	16	uniform	uniform	ADJ
ajbspi-34503	43	17	distribution	distribution	NOUN
ajbspi-34503	43	18	of	of	ADP
ajbspi-34503	43	19	the	the	DET
ajbspi-34503	43	20	drug	drug	NOUN
ajbspi-34503	43	21	particles	particle	NOUN
ajbspi-34503	43	22	.	.	PUNCT
ajbspi-34503	44	1	the	the	DET
ajbspi-34503	44	2	formulation	formulation	NOUN
ajbspi-34503	44	3	parameters	parameter	NOUN
ajbspi-34503	44	4	,	,	PUNCT
ajbspi-34503	44	5	including	include	VERB
ajbspi-34503	44	6	the	the	DET
ajbspi-34503	44	7	concentration	concentration	NOUN
ajbspi-34503	44	8	of	of	ADP
ajbspi-34503	44	9	nanoparticles	nanoparticle	NOUN
ajbspi-34503	44	10	,	,	PUNCT
ajbspi-34503	44	11	viscosity	viscosity	NOUN
ajbspi-34503	44	12	,	,	PUNCT
ajbspi-34503	44	13	ph	ph	VERB
ajbspi-34503	44	14	,	,	PUNCT
ajbspi-34503	44	15	and	and	CCONJ
ajbspi-34503	44	16	stability	stability	NOUN
ajbspi-34503	44	17	,	,	PUNCT
ajbspi-34503	44	18	were	be	AUX
ajbspi-34503	44	19	optimized	optimize	VERB
ajbspi-34503	44	20	to	to	PART
ajbspi-34503	44	21	achieve	achieve	VERB
ajbspi-34503	44	22	the	the	DET
ajbspi-34503	44	23	desired	desire	VERB
ajbspi-34503	44	24	rheological	rheological	ADJ
ajbspi-34503	44	25	properties	property	NOUN
ajbspi-34503	44	26	and	and	CCONJ
ajbspi-34503	44	27	drug	drug	NOUN
ajbspi-34503	44	28	release	release	NOUN
ajbspi-34503	44	29	kinetics	kinetic	NOUN
ajbspi-34503	44	30	.	.	PUNCT
ajbspi-34503	45	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34503	45	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	45	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	45	4	volume	volume	NOUN
ajbspi-34503	45	5	04	04	NUM
ajbspi-34503	45	6	issue	issue	NOUN
ajbspi-34503	45	7	03	03	NUM
ajbspi-34503	45	8	-	-	SYM
ajbspi-34503	45	9	2024	2024	NUM
ajbspi-34503	45	10	13	13	NUM
ajbspi-34503	45	11	american	american	ADJ
ajbspi-34503	45	12	journal	journal	PROPN
ajbspi-34503	45	13	of	of	ADP
ajbspi-34503	45	14	biomedical	biomedical	PROPN
ajbspi-34503	45	15	science	science	PROPN
ajbspi-34503	45	16	&	&	CCONJ
ajbspi-34503	45	17	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	45	18	innovation	innovation	NOUN
ajbspi-34503	45	19	(	(	PUNCT
ajbspi-34503	45	20	issn	issn	PROPN
ajbspi-34503	45	21	–	–	PUNCT
ajbspi-34503	45	22	2771	2771	NUM
ajbspi-34503	45	23	-	-	SYM
ajbspi-34503	45	24	2753	2753	NUM
ajbspi-34503	45	25	)	)	PUNCT
ajbspi-34503	45	26	volume	volume	NOUN
ajbspi-34503	45	27	04	04	NUM
ajbspi-34503	46	1	issue	issue	NOUN
ajbspi-34503	46	2	03	03	NUM
ajbspi-34503	46	3	pages	page	NOUN
ajbspi-34503	46	4	:	:	PUNCT
ajbspi-34503	46	5	9	9	NUM
ajbspi-34503	46	6	-	-	SYM
ajbspi-34503	46	7	17	17	NUM
ajbspi-34503	46	8	sjif	sjif	NOUN
ajbspi-34503	46	9	impact	impact	NOUN
ajbspi-34503	46	10	factor	factor	NOUN
ajbspi-34503	46	11	(	(	PUNCT
ajbspi-34503	46	12	2021	2021	NUM
ajbspi-34503	46	13	:	:	PUNCT
ajbspi-34503	46	14	5	5	NUM
ajbspi-34503	46	15	.	.	NOUN
ajbspi-34503	46	16	705	705	NUM
ajbspi-34503	46	17	)	)	PUNCT
ajbspi-34503	46	18	(	(	PUNCT
ajbspi-34503	46	19	2022	2022	NUM
ajbspi-34503	46	20	:	:	PUNCT
ajbspi-34503	46	21	5	5	NUM
ajbspi-34503	46	22	.	.	NOUN
ajbspi-34503	46	23	705	705	NUM
ajbspi-34503	46	24	)	)	PUNCT
ajbspi-34503	46	25	(	(	PUNCT
ajbspi-34503	46	26	2023	2023	NUM
ajbspi-34503	46	27	:	:	PUNCT
ajbspi-34503	46	28	6.534	6.534	NUM
ajbspi-34503	46	29	)	)	PUNCT
ajbspi-34503	46	30	oclc	oclc	PROPN
ajbspi-34503	46	31	–	–	PUNCT
ajbspi-34503	46	32	1121105677	1121105677	NUM
ajbspi-34503	46	33	publisher	publisher	NOUN
ajbspi-34503	46	34	:	:	PUNCT
ajbspi-34503	46	35	oscar	oscar	NOUN
ajbspi-34503	46	36	publishing	publishing	NOUN
ajbspi-34503	46	37	services	service	NOUN
ajbspi-34503	46	38	servi	servi	PROPN
ajbspi-34503	46	39	drug	drug	PROPN
ajbspi-34503	46	40	release	release	NOUN
ajbspi-34503	46	41	studies	study	NOUN
ajbspi-34503	46	42	:	:	PUNCT
ajbspi-34503	46	43	in	in	ADP
ajbspi-34503	46	44	vitro	vitro	X
ajbspi-34503	47	1	drug	drug	NOUN
ajbspi-34503	47	2	release	release	NOUN
ajbspi-34503	47	3	studies	study	NOUN
ajbspi-34503	47	4	were	be	AUX
ajbspi-34503	47	5	conducted	conduct	VERB
ajbspi-34503	47	6	to	to	PART
ajbspi-34503	47	7	assess	assess	VERB
ajbspi-34503	47	8	the	the	DET
ajbspi-34503	47	9	release	release	NOUN
ajbspi-34503	47	10	profile	profile	NOUN
ajbspi-34503	47	11	of	of	ADP
ajbspi-34503	47	12	fluconazole	fluconazole	NOUN
ajbspi-34503	47	13	from	from	ADP
ajbspi-34503	47	14	the	the	DET
ajbspi-34503	47	15	nanoparticle	nanoparticle	NOUN
ajbspi-34503	47	16	-	-	PUNCT
ajbspi-34503	47	17	based	base	VERB
ajbspi-34503	47	18	topical	topical	ADJ
ajbspi-34503	47	19	gel	gel	NOUN
ajbspi-34503	47	20	.	.	PUNCT
ajbspi-34503	48	1	the	the	DET
ajbspi-34503	48	2	release	release	NOUN
ajbspi-34503	48	3	kinetics	kinetic	NOUN
ajbspi-34503	48	4	were	be	AUX
ajbspi-34503	48	5	evaluated	evaluate	VERB
ajbspi-34503	48	6	using	use	VERB
ajbspi-34503	48	7	standard	standard	ADJ
ajbspi-34503	48	8	dialysis	dialysis	NOUN
ajbspi-34503	48	9	membrane	membrane	NOUN
ajbspi-34503	48	10	or	or	CCONJ
ajbspi-34503	48	11	franz	franz	NOUN
ajbspi-34503	48	12	diffusion	diffusion	NOUN
ajbspi-34503	48	13	cell	cell	NOUN
ajbspi-34503	48	14	methods	method	NOUN
ajbspi-34503	48	15	.	.	PUNCT
ajbspi-34503	49	1	samples	sample	NOUN
ajbspi-34503	49	2	were	be	AUX
ajbspi-34503	49	3	collected	collect	VERB
ajbspi-34503	49	4	at	at	ADP
ajbspi-34503	49	5	predetermined	predetermine	VERB
ajbspi-34503	49	6	time	time	NOUN
ajbspi-34503	49	7	points	point	NOUN
ajbspi-34503	49	8	,	,	PUNCT
ajbspi-34503	49	9	and	and	CCONJ
ajbspi-34503	49	10	the	the	DET
ajbspi-34503	49	11	amount	amount	NOUN
ajbspi-34503	49	12	of	of	ADP
ajbspi-34503	49	13	drug	drug	NOUN
ajbspi-34503	49	14	released	release	VERB
ajbspi-34503	49	15	was	be	AUX
ajbspi-34503	49	16	quantified	quantify	VERB
ajbspi-34503	49	17	using	use	VERB
ajbspi-34503	49	18	validated	validate	VERB
ajbspi-34503	49	19	analytical	analytical	ADJ
ajbspi-34503	49	20	techniques	technique	NOUN
ajbspi-34503	49	21	,	,	PUNCT
ajbspi-34503	49	22	such	such	ADJ
ajbspi-34503	49	23	as	as	ADP
ajbspi-34503	49	24	high	high	ADJ
ajbspi-34503	49	25	-	-	PUNCT
ajbspi-34503	49	26	performance	performance	NOUN
ajbspi-34503	49	27	liquid	liquid	ADJ
ajbspi-34503	49	28	chromatography	chromatography	NOUN
ajbspi-34503	49	29	(	(	PUNCT
ajbspi-34503	49	30	hplc	hplc	PROPN
ajbspi-34503	49	31	)	)	PUNCT
ajbspi-34503	49	32	or	or	CCONJ
ajbspi-34503	49	33	uv	uv	NOUN
ajbspi-34503	49	34	-	-	PUNCT
ajbspi-34503	49	35	visible	visible	ADJ
ajbspi-34503	49	36	spectrophotometry	spectrophotometry	NOUN
ajbspi-34503	49	37	.	.	PUNCT
ajbspi-34503	50	1	antifungal	antifungal	ADJ
ajbspi-34503	50	2	activity	activity	NOUN
ajbspi-34503	50	3	assays	assay	VERB
ajbspi-34503	50	4	:	:	PUNCT
ajbspi-34503	50	5	the	the	DET
ajbspi-34503	50	6	antifungal	antifungal	ADJ
ajbspi-34503	50	7	activity	activity	NOUN
ajbspi-34503	50	8	of	of	ADP
ajbspi-34503	50	9	the	the	DET
ajbspi-34503	50	10	nanoparticle	nanoparticle	NOUN
ajbspi-34503	50	11	-	-	PUNCT
ajbspi-34503	50	12	based	base	VERB
ajbspi-34503	50	13	topical	topical	ADJ
ajbspi-34503	50	14	gel	gel	NOUN
ajbspi-34503	50	15	containing	contain	VERB
ajbspi-34503	50	16	fluconazole	fluconazole	NOUN
ajbspi-34503	50	17	was	be	AUX
ajbspi-34503	50	18	evaluated	evaluate	VERB
ajbspi-34503	50	19	using	use	VERB
ajbspi-34503	50	20	standard	standard	ADJ
ajbspi-34503	50	21	susceptibility	susceptibility	NOUN
ajbspi-34503	50	22	testing	testing	NOUN
ajbspi-34503	50	23	methods	method	NOUN
ajbspi-34503	50	24	,	,	PUNCT
ajbspi-34503	50	25	including	include	VERB
ajbspi-34503	50	26	agar	agar	NOUN
ajbspi-34503	50	27	diffusion	diffusion	NOUN
ajbspi-34503	50	28	or	or	CCONJ
ajbspi-34503	50	29	broth	broth	ADJ
ajbspi-34503	50	30	microdilution	microdilution	NOUN
ajbspi-34503	50	31	assays	assay	NOUN
ajbspi-34503	50	32	.	.	PUNCT
ajbspi-34503	51	1	fungal	fungal	ADJ
ajbspi-34503	51	2	strains	strain	NOUN
ajbspi-34503	51	3	commonly	commonly	ADV
ajbspi-34503	51	4	associated	associate	VERB
ajbspi-34503	51	5	with	with	ADP
ajbspi-34503	51	6	skin	skin	NOUN
ajbspi-34503	51	7	infections	infection	NOUN
ajbspi-34503	51	8	,	,	PUNCT
ajbspi-34503	51	9	such	such	ADJ
ajbspi-34503	51	10	as	as	ADP
ajbspi-34503	51	11	candida	candida	NOUN
ajbspi-34503	51	12	albicans	albican	NOUN
ajbspi-34503	51	13	or	or	CCONJ
ajbspi-34503	51	14	trichophyton	trichophyton	NOUN
ajbspi-34503	51	15	species	specie	NOUN
ajbspi-34503	51	16	,	,	PUNCT
ajbspi-34503	51	17	were	be	AUX
ajbspi-34503	51	18	used	use	VERB
ajbspi-34503	51	19	as	as	ADP
ajbspi-34503	51	20	test	test	NOUN
ajbspi-34503	51	21	organisms	organism	NOUN
ajbspi-34503	51	22	.	.	PUNCT
ajbspi-34503	52	1	the	the	DET
ajbspi-34503	52	2	minimum	minimum	ADJ
ajbspi-34503	52	3	inhibitory	inhibitory	ADJ
ajbspi-34503	52	4	concentration	concentration	NOUN
ajbspi-34503	52	5	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34503	52	6	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	52	7	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	52	8	volume	volume	NOUN
ajbspi-34503	52	9	04	04	NUM
ajbspi-34503	52	10	issue	issue	NOUN
ajbspi-34503	52	11	03	03	NUM
ajbspi-34503	52	12	-	-	SYM
ajbspi-34503	52	13	2024	2024	NUM
ajbspi-34503	52	14	14	14	NUM
ajbspi-34503	52	15	american	american	ADJ
ajbspi-34503	52	16	journal	journal	PROPN
ajbspi-34503	52	17	of	of	ADP
ajbspi-34503	52	18	biomedical	biomedical	PROPN
ajbspi-34503	52	19	science	science	PROPN
ajbspi-34503	52	20	&	&	CCONJ
ajbspi-34503	52	21	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	52	22	innovation	innovation	NOUN
ajbspi-34503	52	23	(	(	PUNCT
ajbspi-34503	52	24	issn	issn	PROPN
ajbspi-34503	52	25	–	–	PUNCT
ajbspi-34503	52	26	2771	2771	NUM
ajbspi-34503	52	27	-	-	SYM
ajbspi-34503	52	28	2753	2753	NUM
ajbspi-34503	52	29	)	)	PUNCT
ajbspi-34503	52	30	volume	volume	NOUN
ajbspi-34503	52	31	04	04	NUM
ajbspi-34503	52	32	issue	issue	NOUN
ajbspi-34503	52	33	03	03	NUM
ajbspi-34503	52	34	pages	page	NOUN
ajbspi-34503	52	35	:	:	PUNCT
ajbspi-34503	52	36	9	9	NUM
ajbspi-34503	52	37	-	-	SYM
ajbspi-34503	52	38	17	17	NUM
ajbspi-34503	52	39	sjif	sjif	NOUN
ajbspi-34503	52	40	impact	impact	NOUN
ajbspi-34503	52	41	factor	factor	NOUN
ajbspi-34503	52	42	(	(	PUNCT
ajbspi-34503	52	43	2021	2021	NUM
ajbspi-34503	52	44	:	:	PUNCT
ajbspi-34503	52	45	5	5	NUM
ajbspi-34503	52	46	.	.	NOUN
ajbspi-34503	52	47	705	705	NUM
ajbspi-34503	52	48	)	)	PUNCT
ajbspi-34503	52	49	(	(	PUNCT
ajbspi-34503	52	50	2022	2022	NUM
ajbspi-34503	52	51	:	:	PUNCT
ajbspi-34503	52	52	5	5	NUM
ajbspi-34503	52	53	.	.	NOUN
ajbspi-34503	52	54	705	705	NUM
ajbspi-34503	52	55	)	)	PUNCT
ajbspi-34503	52	56	(	(	PUNCT
ajbspi-34503	52	57	2023	2023	NUM
ajbspi-34503	52	58	:	:	PUNCT
ajbspi-34503	52	59	6.534	6.534	NUM
ajbspi-34503	52	60	)	)	PUNCT
ajbspi-34503	52	61	oclc	oclc	PROPN
ajbspi-34503	52	62	–	–	PUNCT
ajbspi-34503	52	63	1121105677	1121105677	NUM
ajbspi-34503	52	64	publisher	publisher	NOUN
ajbspi-34503	52	65	:	:	PUNCT
ajbspi-34503	52	66	oscar	oscar	NOUN
ajbspi-34503	52	67	publishing	publishing	NOUN
ajbspi-34503	52	68	services	service	NOUN
ajbspi-34503	52	69	servi	servi	ADJ
ajbspi-34503	52	70	(	(	PUNCT
ajbspi-34503	52	71	mic	mic	ADJ
ajbspi-34503	52	72	)	)	PUNCT
ajbspi-34503	52	73	or	or	CCONJ
ajbspi-34503	52	74	minimum	minimum	ADJ
ajbspi-34503	52	75	fungicidal	fungicidal	ADJ
ajbspi-34503	52	76	concentration	concentration	NOUN
ajbspi-34503	52	77	(	(	PUNCT
ajbspi-34503	52	78	mfc	mfc	NOUN
ajbspi-34503	52	79	)	)	PUNCT
ajbspi-34503	52	80	of	of	ADP
ajbspi-34503	52	81	the	the	DET
ajbspi-34503	52	82	gel	gel	NOUN
ajbspi-34503	52	83	formulation	formulation	NOUN
ajbspi-34503	52	84	was	be	AUX
ajbspi-34503	52	85	determined	determine	VERB
ajbspi-34503	52	86	and	and	CCONJ
ajbspi-34503	52	87	compared	compare	VERB
ajbspi-34503	52	88	to	to	ADP
ajbspi-34503	52	89	that	that	PRON
ajbspi-34503	52	90	of	of	ADP
ajbspi-34503	52	91	conventional	conventional	ADJ
ajbspi-34503	52	92	fluconazole	fluconazole	NOUN
ajbspi-34503	52	93	formulations	formulation	NOUN
ajbspi-34503	52	94	.	.	PUNCT
ajbspi-34503	53	1	skin	skin	NOUN
ajbspi-34503	53	2	permeation	permeation	NOUN
ajbspi-34503	53	3	studies	study	NOUN
ajbspi-34503	53	4	:	:	PUNCT
ajbspi-34503	53	5	skin	skin	NOUN
ajbspi-34503	53	6	permeation	permeation	NOUN
ajbspi-34503	53	7	studies	study	NOUN
ajbspi-34503	53	8	were	be	AUX
ajbspi-34503	53	9	performed	perform	VERB
ajbspi-34503	53	10	using	use	VERB
ajbspi-34503	53	11	franz	franz	NOUN
ajbspi-34503	53	12	diffusion	diffusion	NOUN
ajbspi-34503	53	13	cells	cell	NOUN
ajbspi-34503	53	14	or	or	CCONJ
ajbspi-34503	53	15	other	other	ADJ
ajbspi-34503	53	16	suitable	suitable	ADJ
ajbspi-34503	53	17	diffusion	diffusion	NOUN
ajbspi-34503	53	18	apparatus	apparatus	NOUN
ajbspi-34503	53	19	to	to	PART
ajbspi-34503	53	20	assess	assess	VERB
ajbspi-34503	53	21	the	the	DET
ajbspi-34503	53	22	permeation	permeation	NOUN
ajbspi-34503	53	23	profile	profile	NOUN
ajbspi-34503	53	24	of	of	ADP
ajbspi-34503	53	25	fluconazole	fluconazole	NOUN
ajbspi-34503	53	26	from	from	ADP
ajbspi-34503	53	27	the	the	DET
ajbspi-34503	53	28	nanoparticle	nanoparticle	NOUN
ajbspi-34503	53	29	-	-	PUNCT
ajbspi-34503	53	30	based	base	VERB
ajbspi-34503	53	31	topical	topical	ADJ
ajbspi-34503	53	32	gel	gel	NOUN
ajbspi-34503	53	33	across	across	ADP
ajbspi-34503	53	34	the	the	DET
ajbspi-34503	53	35	skin	skin	NOUN
ajbspi-34503	53	36	barrier	barrier	NOUN
ajbspi-34503	53	37	.	.	PUNCT
ajbspi-34503	54	1	excised	excise	VERB
ajbspi-34503	54	2	animal	animal	NOUN
ajbspi-34503	54	3	or	or	CCONJ
ajbspi-34503	54	4	human	human	ADJ
ajbspi-34503	54	5	skin	skin	NOUN
ajbspi-34503	54	6	samples	sample	NOUN
ajbspi-34503	54	7	were	be	AUX
ajbspi-34503	54	8	mounted	mount	VERB
ajbspi-34503	54	9	between	between	ADP
ajbspi-34503	54	10	the	the	DET
ajbspi-34503	54	11	donor	donor	NOUN
ajbspi-34503	54	12	and	and	CCONJ
ajbspi-34503	54	13	receptor	receptor	NOUN
ajbspi-34503	54	14	compartments	compartment	NOUN
ajbspi-34503	54	15	,	,	PUNCT
ajbspi-34503	54	16	and	and	CCONJ
ajbspi-34503	54	17	the	the	DET
ajbspi-34503	54	18	cumulative	cumulative	ADJ
ajbspi-34503	54	19	amount	amount	NOUN
ajbspi-34503	54	20	of	of	ADP
ajbspi-34503	54	21	drug	drug	NOUN
ajbspi-34503	54	22	permeated	permeate	VERB
ajbspi-34503	54	23	through	through	ADP
ajbspi-34503	54	24	the	the	DET
ajbspi-34503	54	25	skin	skin	NOUN
ajbspi-34503	54	26	was	be	AUX
ajbspi-34503	54	27	quantified	quantify	VERB
ajbspi-34503	54	28	over	over	ADP
ajbspi-34503	54	29	time	time	NOUN
ajbspi-34503	54	30	using	use	VERB
ajbspi-34503	54	31	validated	validated	ADJ
ajbspi-34503	54	32	analytical	analytical	ADJ
ajbspi-34503	54	33	methods	method	NOUN
ajbspi-34503	54	34	.	.	PUNCT
ajbspi-34503	55	1	safety	safety	NOUN
ajbspi-34503	55	2	and	and	CCONJ
ajbspi-34503	55	3	stability	stability	NOUN
ajbspi-34503	55	4	assessments	assessment	NOUN
ajbspi-34503	55	5	:	:	PUNCT
ajbspi-34503	55	6	the	the	DET
ajbspi-34503	55	7	safety	safety	NOUN
ajbspi-34503	55	8	and	and	CCONJ
ajbspi-34503	55	9	stability	stability	NOUN
ajbspi-34503	55	10	of	of	ADP
ajbspi-34503	55	11	the	the	DET
ajbspi-34503	55	12	nanoparticle	nanoparticle	NOUN
ajbspi-34503	55	13	-	-	PUNCT
ajbspi-34503	55	14	based	base	VERB
ajbspi-34503	55	15	topical	topical	ADJ
ajbspi-34503	55	16	gel	gel	NOUN
ajbspi-34503	55	17	formulation	formulation	NOUN
ajbspi-34503	55	18	were	be	AUX
ajbspi-34503	55	19	evaluated	evaluate	VERB
ajbspi-34503	55	20	through	through	ADP
ajbspi-34503	55	21	cytotoxicity	cytotoxicity	NOUN
ajbspi-34503	55	22	assays	assay	NOUN
ajbspi-34503	55	23	using	use	VERB
ajbspi-34503	55	24	appropriate	appropriate	ADJ
ajbspi-34503	55	25	cell	cell	NOUN
ajbspi-34503	55	26	lines	line	NOUN
ajbspi-34503	55	27	and	and	CCONJ
ajbspi-34503	55	28	histological	histological	ADJ
ajbspi-34503	55	29	examination	examination	NOUN
ajbspi-34503	55	30	of	of	ADP
ajbspi-34503	55	31	skin	skin	NOUN
ajbspi-34503	55	32	samples	sample	NOUN
ajbspi-34503	55	33	.	.	PUNCT
ajbspi-34503	56	1	furthermore	furthermore	ADV
ajbspi-34503	56	2	,	,	PUNCT
ajbspi-34503	56	3	the	the	DET
ajbspi-34503	56	4	physical	physical	ADJ
ajbspi-34503	56	5	and	and	CCONJ
ajbspi-34503	56	6	chemical	chemical	NOUN
ajbspi-34503	56	7	stability	stability	NOUN
ajbspi-34503	56	8	of	of	ADP
ajbspi-34503	56	9	the	the	DET
ajbspi-34503	56	10	formulation	formulation	NOUN
ajbspi-34503	56	11	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34503	56	12	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	56	13	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	56	14	volume	volume	NOUN
ajbspi-34503	56	15	04	04	NUM
ajbspi-34503	56	16	issue	issue	NOUN
ajbspi-34503	56	17	03	03	NUM
ajbspi-34503	56	18	-	-	SYM
ajbspi-34503	56	19	2024	2024	NUM
ajbspi-34503	56	20	15	15	NUM
ajbspi-34503	56	21	american	american	ADJ
ajbspi-34503	56	22	journal	journal	PROPN
ajbspi-34503	56	23	of	of	ADP
ajbspi-34503	56	24	biomedical	biomedical	PROPN
ajbspi-34503	56	25	science	science	PROPN
ajbspi-34503	56	26	&	&	CCONJ
ajbspi-34503	56	27	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	56	28	innovation	innovation	NOUN
ajbspi-34503	56	29	(	(	PUNCT
ajbspi-34503	56	30	issn	issn	PROPN
ajbspi-34503	56	31	–	–	PUNCT
ajbspi-34503	56	32	2771	2771	NUM
ajbspi-34503	56	33	-	-	SYM
ajbspi-34503	56	34	2753	2753	NUM
ajbspi-34503	56	35	)	)	PUNCT
ajbspi-34503	56	36	volume	volume	NOUN
ajbspi-34503	56	37	04	04	NUM
ajbspi-34503	56	38	issue	issue	NOUN
ajbspi-34503	56	39	03	03	NUM
ajbspi-34503	56	40	pages	page	NOUN
ajbspi-34503	56	41	:	:	PUNCT
ajbspi-34503	56	42	9	9	NUM
ajbspi-34503	56	43	-	-	SYM
ajbspi-34503	56	44	17	17	NUM
ajbspi-34503	56	45	sjif	sjif	NOUN
ajbspi-34503	56	46	impact	impact	NOUN
ajbspi-34503	56	47	factor	factor	NOUN
ajbspi-34503	56	48	(	(	PUNCT
ajbspi-34503	56	49	2021	2021	NUM
ajbspi-34503	56	50	:	:	PUNCT
ajbspi-34503	56	51	5	5	NUM
ajbspi-34503	56	52	.	.	NOUN
ajbspi-34503	56	53	705	705	NUM
ajbspi-34503	56	54	)	)	PUNCT
ajbspi-34503	56	55	(	(	PUNCT
ajbspi-34503	56	56	2022	2022	NUM
ajbspi-34503	56	57	:	:	PUNCT
ajbspi-34503	56	58	5	5	NUM
ajbspi-34503	56	59	.	.	NOUN
ajbspi-34503	56	60	705	705	NUM
ajbspi-34503	56	61	)	)	PUNCT
ajbspi-34503	56	62	(	(	PUNCT
ajbspi-34503	56	63	2023	2023	NUM
ajbspi-34503	56	64	:	:	PUNCT
ajbspi-34503	56	65	6.534	6.534	NUM
ajbspi-34503	56	66	)	)	PUNCT
ajbspi-34503	56	67	oclc	oclc	PROPN
ajbspi-34503	56	68	–	–	PUNCT
ajbspi-34503	56	69	1121105677	1121105677	NUM
ajbspi-34503	56	70	publisher	publisher	NOUN
ajbspi-34503	56	71	:	:	PUNCT
ajbspi-34503	56	72	oscar	oscar	NOUN
ajbspi-34503	56	73	publishing	publishing	NOUN
ajbspi-34503	56	74	services	service	NOUN
ajbspi-34503	56	75	servi	servi	PROPN
ajbspi-34503	56	76	was	be	AUX
ajbspi-34503	56	77	assessed	assess	VERB
ajbspi-34503	56	78	under	under	ADP
ajbspi-34503	56	79	various	various	ADJ
ajbspi-34503	56	80	storage	storage	NOUN
ajbspi-34503	56	81	conditions	condition	NOUN
ajbspi-34503	56	82	,	,	PUNCT
ajbspi-34503	56	83	including	include	VERB
ajbspi-34503	56	84	temperature	temperature	NOUN
ajbspi-34503	56	85	,	,	PUNCT
ajbspi-34503	56	86	humidity	humidity	NOUN
ajbspi-34503	56	87	,	,	PUNCT
ajbspi-34503	56	88	and	and	CCONJ
ajbspi-34503	56	89	light	light	ADJ
ajbspi-34503	56	90	exposure	exposure	NOUN
ajbspi-34503	56	91	,	,	PUNCT
ajbspi-34503	56	92	over	over	ADP
ajbspi-34503	56	93	a	a	DET
ajbspi-34503	56	94	specified	specified	ADJ
ajbspi-34503	56	95	period	period	NOUN
ajbspi-34503	56	96	.	.	PUNCT
ajbspi-34503	57	1	overall	overall	ADV
ajbspi-34503	57	2	,	,	PUNCT
ajbspi-34503	57	3	the	the	DET
ajbspi-34503	57	4	methodological	methodological	ADJ
ajbspi-34503	57	5	approach	approach	NOUN
ajbspi-34503	57	6	encompassing	encompass	VERB
ajbspi-34503	57	7	nanoparticle	nanoparticle	NOUN
ajbspi-34503	57	8	synthesis	synthesis	NOUN
ajbspi-34503	57	9	,	,	PUNCT
ajbspi-34503	57	10	formulation	formulation	NOUN
ajbspi-34503	57	11	development	development	NOUN
ajbspi-34503	57	12	,	,	PUNCT
ajbspi-34503	57	13	characterization	characterization	NOUN
ajbspi-34503	57	14	,	,	PUNCT
ajbspi-34503	57	15	and	and	CCONJ
ajbspi-34503	57	16	evaluation	evaluation	NOUN
ajbspi-34503	57	17	provides	provide	VERB
ajbspi-34503	57	18	a	a	DET
ajbspi-34503	57	19	comprehensive	comprehensive	ADJ
ajbspi-34503	57	20	understanding	understanding	NOUN
ajbspi-34503	57	21	of	of	ADP
ajbspi-34503	57	22	the	the	DET
ajbspi-34503	57	23	potential	potential	NOUN
ajbspi-34503	57	24	of	of	ADP
ajbspi-34503	57	25	the	the	DET
ajbspi-34503	57	26	nanoparticle	nanoparticle	NOUN
ajbspi-34503	57	27	-	-	PUNCT
ajbspi-34503	57	28	based	base	VERB
ajbspi-34503	57	29	topical	topical	ADJ
ajbspi-34503	57	30	gel	gel	NOUN
ajbspi-34503	57	31	containing	contain	VERB
ajbspi-34503	57	32	fluconazole	fluconazole	NOUN
ajbspi-34503	57	33	as	as	ADP
ajbspi-34503	57	34	a	a	DET
ajbspi-34503	57	35	promising	promising	ADJ
ajbspi-34503	57	36	antifungal	antifungal	ADJ
ajbspi-34503	57	37	treatment	treatment	NOUN
ajbspi-34503	57	38	.	.	PUNCT
ajbspi-34503	58	1	results	result	VERB
ajbspi-34503	58	2	the	the	DET
ajbspi-34503	58	3	formulation	formulation	NOUN
ajbspi-34503	58	4	and	and	CCONJ
ajbspi-34503	58	5	evaluation	evaluation	NOUN
ajbspi-34503	58	6	of	of	ADP
ajbspi-34503	58	7	the	the	DET
ajbspi-34503	58	8	nanoparticlebased	nanoparticlebased	ADJ
ajbspi-34503	58	9	topical	topical	ADJ
ajbspi-34503	58	10	gel	gel	NOUN
ajbspi-34503	58	11	containing	contain	VERB
ajbspi-34503	58	12	fluconazole	fluconazole	NOUN
ajbspi-34503	58	13	yielded	yield	VERB
ajbspi-34503	58	14	promising	promising	ADJ
ajbspi-34503	58	15	results	result	NOUN
ajbspi-34503	58	16	regarding	regard	VERB
ajbspi-34503	58	17	its	its	PRON
ajbspi-34503	58	18	potential	potential	NOUN
ajbspi-34503	58	19	as	as	ADP
ajbspi-34503	58	20	an	an	DET
ajbspi-34503	58	21	antifungal	antifungal	ADJ
ajbspi-34503	58	22	treatment	treatment	NOUN
ajbspi-34503	58	23	.	.	PUNCT
ajbspi-34503	59	1	the	the	DET
ajbspi-34503	59	2	synthesized	synthesize	VERB
ajbspi-34503	59	3	nanoparticles	nanoparticle	NOUN
ajbspi-34503	59	4	exhibited	exhibit	VERB
ajbspi-34503	59	5	uniform	uniform	ADJ
ajbspi-34503	59	6	size	size	NOUN
ajbspi-34503	59	7	,	,	PUNCT
ajbspi-34503	59	8	desirable	desirable	ADJ
ajbspi-34503	59	9	morphology	morphology	NOUN
ajbspi-34503	59	10	,	,	PUNCT
ajbspi-34503	59	11	and	and	CCONJ
ajbspi-34503	59	12	high	high	ADJ
ajbspi-34503	59	13	drug	drug	NOUN
ajbspi-34503	59	14	loading	loading	NOUN
ajbspi-34503	59	15	efficiency	efficiency	NOUN
ajbspi-34503	59	16	,	,	PUNCT
ajbspi-34503	59	17	as	as	SCONJ
ajbspi-34503	59	18	confirmed	confirm	VERB
ajbspi-34503	59	19	by	by	ADP
ajbspi-34503	59	20	dynamic	dynamic	ADJ
ajbspi-34503	59	21	light	light	NOUN
ajbspi-34503	59	22	scattering	scattering	NOUN
ajbspi-34503	59	23	and	and	CCONJ
ajbspi-34503	59	24	electron	electron	NOUN
ajbspi-34503	59	25	microscopy	microscopy	NOUN
ajbspi-34503	59	26	analyses	analysis	NOUN
ajbspi-34503	59	27	.	.	PUNCT
ajbspi-34503	60	1	the	the	DET
ajbspi-34503	60	2	topical	topical	ADJ
ajbspi-34503	60	3	gel	gel	NOUN
ajbspi-34503	60	4	formulation	formulation	NOUN
ajbspi-34503	60	5	demonstrated	demonstrate	VERB
ajbspi-34503	60	6	optimal	optimal	ADJ
ajbspi-34503	60	7	rheological	rheological	ADJ
ajbspi-34503	60	8	properties	property	NOUN
ajbspi-34503	60	9	,	,	PUNCT
ajbspi-34503	60	10	stability	stability	NOUN
ajbspi-34503	60	11	,	,	PUNCT
ajbspi-34503	60	12	and	and	CCONJ
ajbspi-34503	60	13	sustained	sustain	VERB
ajbspi-34503	60	14	release	release	NOUN
ajbspi-34503	60	15	of	of	ADP
ajbspi-34503	60	16	fluconazole	fluconazole	NOUN
ajbspi-34503	60	17	over	over	ADP
ajbspi-34503	60	18	time	time	NOUN
ajbspi-34503	60	19	,	,	PUNCT
ajbspi-34503	60	20	as	as	SCONJ
ajbspi-34503	60	21	evidenced	evidence	VERB
ajbspi-34503	60	22	by	by	ADP
ajbspi-34503	60	23	in	in	ADP
ajbspi-34503	60	24	vitro	vitro	X
ajbspi-34503	60	25	drug	drug	NOUN
ajbspi-34503	60	26	release	release	NOUN
ajbspi-34503	60	27	studies	study	NOUN
ajbspi-34503	60	28	.	.	PUNCT
ajbspi-34503	61	1	antifungal	antifungal	ADJ
ajbspi-34503	61	2	activity	activity	NOUN
ajbspi-34503	61	3	assays	assay	NOUN
ajbspi-34503	61	4	revealed	reveal	VERB
ajbspi-34503	61	5	that	that	SCONJ
ajbspi-34503	61	6	the	the	DET
ajbspi-34503	61	7	nanoparticle	nanoparticle	NOUN
ajbspi-34503	61	8	-	-	PUNCT
ajbspi-34503	61	9	based	base	VERB
ajbspi-34503	61	10	topical	topical	ADJ
ajbspi-34503	61	11	gel	gel	NOUN
ajbspi-34503	61	12	effectively	effectively	ADV
ajbspi-34503	61	13	inhibited	inhibit	VERB
ajbspi-34503	61	14	the	the	DET
ajbspi-34503	61	15	growth	growth	NOUN
ajbspi-34503	61	16	of	of	ADP
ajbspi-34503	61	17	clinically	clinically	ADV
ajbspi-34503	61	18	relevant	relevant	ADJ
ajbspi-34503	61	19	fungal	fungal	ADJ
ajbspi-34503	61	20	strains	strain	NOUN
ajbspi-34503	61	21	,	,	PUNCT
ajbspi-34503	61	22	including	include	VERB
ajbspi-34503	61	23	candida	candida	NOUN
ajbspi-34503	61	24	albicans	albican	NOUN
ajbspi-34503	61	25	and	and	CCONJ
ajbspi-34503	61	26	trichophyton	trichophyton	NOUN
ajbspi-34503	61	27	species	specie	NOUN
ajbspi-34503	61	28	.	.	PUNCT
ajbspi-34503	62	1	the	the	DET
ajbspi-34503	62	2	minimum	minimum	ADJ
ajbspi-34503	62	3	inhibitory	inhibitory	ADJ
ajbspi-34503	62	4	concentration	concentration	NOUN
ajbspi-34503	62	5	(	(	PUNCT
ajbspi-34503	62	6	mic	mic	ADJ
ajbspi-34503	62	7	)	)	PUNCT
ajbspi-34503	62	8	and	and	CCONJ
ajbspi-34503	62	9	minimum	minimum	ADJ
ajbspi-34503	62	10	fungicidal	fungicidal	ADJ
ajbspi-34503	62	11	concentration	concentration	NOUN
ajbspi-34503	62	12	(	(	PUNCT
ajbspi-34503	62	13	mfc	mfc	NOUN
ajbspi-34503	62	14	)	)	PUNCT
ajbspi-34503	62	15	of	of	ADP
ajbspi-34503	62	16	the	the	DET
ajbspi-34503	62	17	gel	gel	NOUN
ajbspi-34503	62	18	formulation	formulation	NOUN
ajbspi-34503	62	19	were	be	AUX
ajbspi-34503	62	20	comparable	comparable	ADJ
ajbspi-34503	62	21	to	to	ADP
ajbspi-34503	62	22	or	or	CCONJ
ajbspi-34503	62	23	lower	low	ADJ
ajbspi-34503	62	24	than	than	ADP
ajbspi-34503	62	25	those	those	PRON
ajbspi-34503	62	26	of	of	ADP
ajbspi-34503	62	27	conventional	conventional	ADJ
ajbspi-34503	62	28	fluconazole	fluconazole	NOUN
ajbspi-34503	62	29	formulations	formulation	NOUN
ajbspi-34503	62	30	,	,	PUNCT
ajbspi-34503	62	31	highlighting	highlight	VERB
ajbspi-34503	62	32	its	its	PRON
ajbspi-34503	62	33	potent	potent	ADJ
ajbspi-34503	62	34	antifungal	antifungal	ADJ
ajbspi-34503	62	35	efficacy	efficacy	NOUN
ajbspi-34503	62	36	.	.	PUNCT
ajbspi-34503	63	1	skin	skin	NOUN
ajbspi-34503	63	2	permeation	permeation	NOUN
ajbspi-34503	63	3	studies	study	NOUN
ajbspi-34503	63	4	demonstrated	demonstrate	VERB
ajbspi-34503	63	5	the	the	DET
ajbspi-34503	63	6	ability	ability	NOUN
ajbspi-34503	63	7	of	of	ADP
ajbspi-34503	63	8	the	the	DET
ajbspi-34503	63	9	nanoparticle	nanoparticle	NOUN
ajbspi-34503	63	10	-	-	PUNCT
ajbspi-34503	63	11	based	base	VERB
ajbspi-34503	63	12	topical	topical	ADJ
ajbspi-34503	63	13	gel	gel	NOUN
ajbspi-34503	63	14	to	to	PART
ajbspi-34503	63	15	efficiently	efficiently	ADV
ajbspi-34503	63	16	deliver	deliver	VERB
ajbspi-34503	63	17	fluconazole	fluconazole	NOUN
ajbspi-34503	63	18	across	across	ADP
ajbspi-34503	63	19	the	the	DET
ajbspi-34503	63	20	skin	skin	NOUN
ajbspi-34503	63	21	barrier	barrier	NOUN
ajbspi-34503	63	22	,	,	PUNCT
ajbspi-34503	63	23	with	with	ADP
ajbspi-34503	63	24	sustained	sustained	ADJ
ajbspi-34503	63	25	release	release	NOUN
ajbspi-34503	63	26	kinetics	kinetic	NOUN
ajbspi-34503	63	27	conducive	conducive	ADJ
ajbspi-34503	63	28	to	to	ADP
ajbspi-34503	63	29	prolonged	prolong	VERB
ajbspi-34503	63	30	therapeutic	therapeutic	ADJ
ajbspi-34503	63	31	activity	activity	NOUN
ajbspi-34503	63	32	.	.	PUNCT
ajbspi-34503	64	1	safety	safety	NOUN
ajbspi-34503	64	2	assessments	assessment	NOUN
ajbspi-34503	64	3	indicated	indicate	VERB
ajbspi-34503	64	4	that	that	SCONJ
ajbspi-34503	64	5	the	the	DET
ajbspi-34503	64	6	formulation	formulation	NOUN
ajbspi-34503	64	7	was	be	AUX
ajbspi-34503	64	8	well	well	ADV
ajbspi-34503	64	9	-	-	PUNCT
ajbspi-34503	64	10	tolerated	tolerate	VERB
ajbspi-34503	64	11	,	,	PUNCT
ajbspi-34503	64	12	with	with	ADP
ajbspi-34503	64	13	no	no	DET
ajbspi-34503	64	14	significant	significant	ADJ
ajbspi-34503	64	15	cytotoxic	cytotoxic	ADJ
ajbspi-34503	64	16	effects	effect	NOUN
ajbspi-34503	64	17	observed	observe	VERB
ajbspi-34503	64	18	in	in	ADP
ajbspi-34503	64	19	vitro	vitro	X
ajbspi-34503	64	20	and	and	CCONJ
ajbspi-34503	64	21	no	no	DET
ajbspi-34503	64	22	adverse	adverse	ADJ
ajbspi-34503	64	23	reactions	reaction	NOUN
ajbspi-34503	64	24	noted	note	VERB
ajbspi-34503	64	25	upon	upon	SCONJ
ajbspi-34503	64	26	histological	histological	ADJ
ajbspi-34503	64	27	examination	examination	NOUN
ajbspi-34503	64	28	of	of	ADP
ajbspi-34503	64	29	skin	skin	NOUN
ajbspi-34503	64	30	samples	sample	NOUN
ajbspi-34503	64	31	.	.	PUNCT
ajbspi-34503	65	1	discussion	discussion	NOUN
ajbspi-34503	65	2	the	the	DET
ajbspi-34503	65	3	successful	successful	ADJ
ajbspi-34503	65	4	formulation	formulation	NOUN
ajbspi-34503	65	5	and	and	CCONJ
ajbspi-34503	65	6	evaluation	evaluation	NOUN
ajbspi-34503	65	7	of	of	ADP
ajbspi-34503	65	8	the	the	DET
ajbspi-34503	65	9	nanoparticle	nanoparticle	NOUN
ajbspi-34503	65	10	-	-	PUNCT
ajbspi-34503	65	11	based	base	VERB
ajbspi-34503	65	12	topical	topical	ADJ
ajbspi-34503	65	13	gel	gel	NOUN
ajbspi-34503	65	14	with	with	ADP
ajbspi-34503	65	15	fluconazole	fluconazole	NOUN
ajbspi-34503	65	16	represent	represent	VERB
ajbspi-34503	65	17	a	a	DET
ajbspi-34503	65	18	significant	significant	ADJ
ajbspi-34503	65	19	advancement	advancement	NOUN
ajbspi-34503	65	20	in	in	ADP
ajbspi-34503	65	21	antifungal	antifungal	ADJ
ajbspi-34503	65	22	therapy	therapy	NOUN
ajbspi-34503	65	23	.	.	PUNCT
ajbspi-34503	66	1	the	the	DET
ajbspi-34503	66	2	use	use	NOUN
ajbspi-34503	66	3	of	of	ADP
ajbspi-34503	66	4	nanoparticles	nanoparticle	NOUN
ajbspi-34503	66	5	as	as	ADP
ajbspi-34503	66	6	carriers	carrier	NOUN
ajbspi-34503	66	7	for	for	ADP
ajbspi-34503	66	8	fluconazole	fluconazole	NOUN
ajbspi-34503	66	9	offers	offer	VERB
ajbspi-34503	66	10	several	several	ADJ
ajbspi-34503	66	11	advantages	advantage	NOUN
ajbspi-34503	66	12	,	,	PUNCT
ajbspi-34503	66	13	including	include	VERB
ajbspi-34503	66	14	enhanced	enhance	VERB
ajbspi-34503	66	15	drug	drug	NOUN
ajbspi-34503	66	16	stability	stability	NOUN
ajbspi-34503	66	17	,	,	PUNCT
ajbspi-34503	66	18	controlled	control	VERB
ajbspi-34503	66	19	release	release	NOUN
ajbspi-34503	66	20	kinetics	kinetic	NOUN
ajbspi-34503	66	21	,	,	PUNCT
ajbspi-34503	66	22	and	and	CCONJ
ajbspi-34503	66	23	targeted	target	VERB
ajbspi-34503	66	24	delivery	delivery	NOUN
ajbspi-34503	66	25	to	to	ADP
ajbspi-34503	66	26	the	the	DET
ajbspi-34503	66	27	site	site	NOUN
ajbspi-34503	66	28	of	of	ADP
ajbspi-34503	66	29	infection	infection	NOUN
ajbspi-34503	66	30	.	.	PUNCT
ajbspi-34503	67	1	the	the	DET
ajbspi-34503	67	2	sustained	sustain	VERB
ajbspi-34503	67	3	release	release	NOUN
ajbspi-34503	67	4	of	of	ADP
ajbspi-34503	67	5	fluconazole	fluconazole	NOUN
ajbspi-34503	67	6	from	from	ADP
ajbspi-34503	67	7	the	the	DET
ajbspi-34503	67	8	gel	gel	NOUN
ajbspi-34503	67	9	matrix	matrix	NOUN
ajbspi-34503	67	10	ensures	ensure	VERB
ajbspi-34503	67	11	prolonged	prolonged	ADJ
ajbspi-34503	67	12	exposure	exposure	NOUN
ajbspi-34503	67	13	to	to	ADP
ajbspi-34503	67	14	therapeutic	therapeutic	ADJ
ajbspi-34503	67	15	concentrations	concentration	NOUN
ajbspi-34503	67	16	,	,	PUNCT
ajbspi-34503	67	17	thereby	thereby	ADV
ajbspi-34503	67	18	improving	improve	VERB
ajbspi-34503	67	19	treatment	treatment	NOUN
ajbspi-34503	67	20	efficacy	efficacy	NOUN
ajbspi-34503	67	21	and	and	CCONJ
ajbspi-34503	67	22	patient	patient	ADJ
ajbspi-34503	67	23	compliance	compliance	NOUN
ajbspi-34503	67	24	.	.	PUNCT
ajbspi-34503	68	1	the	the	DET
ajbspi-34503	68	2	potent	potent	ADJ
ajbspi-34503	68	3	antifungal	antifungal	ADJ
ajbspi-34503	68	4	activity	activity	NOUN
ajbspi-34503	68	5	exhibited	exhibit	VERB
ajbspi-34503	68	6	by	by	ADP
ajbspi-34503	68	7	the	the	DET
ajbspi-34503	68	8	nanoparticle	nanoparticle	NOUN
ajbspi-34503	68	9	-	-	PUNCT
ajbspi-34503	68	10	based	base	VERB
ajbspi-34503	68	11	topical	topical	ADJ
ajbspi-34503	68	12	gel	gel	NOUN
ajbspi-34503	68	13	underscores	underscore	VERB
ajbspi-34503	68	14	its	its	PRON
ajbspi-34503	68	15	potential	potential	NOUN
ajbspi-34503	68	16	as	as	ADP
ajbspi-34503	68	17	a	a	DET
ajbspi-34503	68	18	promising	promising	ADJ
ajbspi-34503	68	19	alternative	alternative	NOUN
ajbspi-34503	68	20	to	to	ADP
ajbspi-34503	68	21	conventional	conventional	ADJ
ajbspi-34503	68	22	fluconazole	fluconazole	NOUN
ajbspi-34503	68	23	formulations	formulation	NOUN
ajbspi-34503	68	24	for	for	ADP
ajbspi-34503	68	25	the	the	DET
ajbspi-34503	68	26	management	management	NOUN
ajbspi-34503	68	27	of	of	ADP
ajbspi-34503	68	28	fungal	fungal	ADJ
ajbspi-34503	68	29	infections	infection	NOUN
ajbspi-34503	68	30	.	.	PUNCT
ajbspi-34503	69	1	the	the	DET
ajbspi-34503	69	2	ability	ability	NOUN
ajbspi-34503	69	3	to	to	PART
ajbspi-34503	69	4	inhibit	inhibit	VERB
ajbspi-34503	69	5	the	the	DET
ajbspi-34503	69	6	growth	growth	NOUN
ajbspi-34503	69	7	of	of	ADP
ajbspi-34503	69	8	clinically	clinically	ADV
ajbspi-34503	69	9	relevant	relevant	ADJ
ajbspi-34503	69	10	fungal	fungal	ADJ
ajbspi-34503	69	11	strains	strain	NOUN
ajbspi-34503	69	12	,	,	PUNCT
ajbspi-34503	69	13	coupled	couple	VERB
ajbspi-34503	69	14	with	with	ADP
ajbspi-34503	69	15	efficient	efficient	ADJ
ajbspi-34503	69	16	skin	skin	NOUN
ajbspi-34503	69	17	permeation	permeation	NOUN
ajbspi-34503	69	18	and	and	CCONJ
ajbspi-34503	69	19	sustained	sustained	ADJ
ajbspi-34503	69	20	drug	drug	NOUN
ajbspi-34503	69	21	release	release	NOUN
ajbspi-34503	69	22	,	,	PUNCT
ajbspi-34503	69	23	positions	position	VERB
ajbspi-34503	69	24	the	the	DET
ajbspi-34503	69	25	gel	gel	NOUN
ajbspi-34503	69	26	formulation	formulation	NOUN
ajbspi-34503	69	27	as	as	ADP
ajbspi-34503	69	28	a	a	DET
ajbspi-34503	69	29	versatile	versatile	ADJ
ajbspi-34503	69	30	and	and	CCONJ
ajbspi-34503	69	31	effective	effective	ADJ
ajbspi-34503	69	32	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34503	69	33	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34503	69	34	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	69	35	volume	volume	NOUN
ajbspi-34503	69	36	04	04	NUM
ajbspi-34503	69	37	issue	issue	NOUN
ajbspi-34503	69	38	03	03	NUM
ajbspi-34503	69	39	-	-	SYM
ajbspi-34503	69	40	2024	2024	NUM
ajbspi-34503	69	41	16	16	NUM
ajbspi-34503	69	42	american	american	ADJ
ajbspi-34503	69	43	journal	journal	PROPN
ajbspi-34503	69	44	of	of	ADP
ajbspi-34503	69	45	biomedical	biomedical	PROPN
ajbspi-34503	69	46	science	science	PROPN
ajbspi-34503	69	47	&	&	CCONJ
ajbspi-34503	69	48	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	69	49	innovation	innovation	NOUN
ajbspi-34503	69	50	(	(	PUNCT
ajbspi-34503	69	51	issn	issn	PROPN
ajbspi-34503	69	52	–	–	PUNCT
ajbspi-34503	69	53	2771	2771	NUM
ajbspi-34503	69	54	-	-	SYM
ajbspi-34503	69	55	2753	2753	NUM
ajbspi-34503	69	56	)	)	PUNCT
ajbspi-34503	69	57	volume	volume	NOUN
ajbspi-34503	69	58	04	04	NUM
ajbspi-34503	69	59	issue	issue	NOUN
ajbspi-34503	69	60	03	03	NUM
ajbspi-34503	69	61	pages	page	NOUN
ajbspi-34503	69	62	:	:	PUNCT
ajbspi-34503	69	63	9	9	NUM
ajbspi-34503	69	64	-	-	SYM
ajbspi-34503	69	65	17	17	NUM
ajbspi-34503	69	66	sjif	sjif	NOUN
ajbspi-34503	69	67	impact	impact	NOUN
ajbspi-34503	69	68	factor	factor	NOUN
ajbspi-34503	69	69	(	(	PUNCT
ajbspi-34503	69	70	2021	2021	NUM
ajbspi-34503	69	71	:	:	PUNCT
ajbspi-34503	69	72	5	5	NUM
ajbspi-34503	69	73	.	.	NOUN
ajbspi-34503	69	74	705	705	NUM
ajbspi-34503	69	75	)	)	PUNCT
ajbspi-34503	69	76	(	(	PUNCT
ajbspi-34503	69	77	2022	2022	NUM
ajbspi-34503	69	78	:	:	PUNCT
ajbspi-34503	69	79	5	5	NUM
ajbspi-34503	69	80	.	.	NOUN
ajbspi-34503	69	81	705	705	NUM
ajbspi-34503	69	82	)	)	PUNCT
ajbspi-34503	69	83	(	(	PUNCT
ajbspi-34503	69	84	2023	2023	NUM
ajbspi-34503	69	85	:	:	PUNCT
ajbspi-34503	69	86	6.534	6.534	NUM
ajbspi-34503	69	87	)	)	PUNCT
ajbspi-34503	69	88	oclc	oclc	PROPN
ajbspi-34503	69	89	–	–	PUNCT
ajbspi-34503	69	90	1121105677	1121105677	NUM
ajbspi-34503	69	91	publisher	publisher	NOUN
ajbspi-34503	69	92	:	:	PUNCT
ajbspi-34503	69	93	oscar	oscar	NOUN
ajbspi-34503	69	94	publishing	publishing	NOUN
ajbspi-34503	69	95	services	service	NOUN
ajbspi-34503	69	96	servi	servi	ADJ
ajbspi-34503	69	97	treatment	treatment	NOUN
ajbspi-34503	69	98	option	option	NOUN
ajbspi-34503	69	99	for	for	ADP
ajbspi-34503	69	100	a	a	DET
ajbspi-34503	69	101	wide	wide	ADJ
ajbspi-34503	69	102	range	range	NOUN
ajbspi-34503	69	103	of	of	ADP
ajbspi-34503	69	104	dermatological	dermatological	ADJ
ajbspi-34503	69	105	conditions	condition	NOUN
ajbspi-34503	69	106	.	.	PUNCT
ajbspi-34503	70	1	furthermore	furthermore	ADV
ajbspi-34503	70	2	,	,	PUNCT
ajbspi-34503	70	3	the	the	DET
ajbspi-34503	70	4	safety	safety	NOUN
ajbspi-34503	70	5	profile	profile	NOUN
ajbspi-34503	70	6	of	of	ADP
ajbspi-34503	70	7	the	the	DET
ajbspi-34503	70	8	nanoparticlebased	nanoparticlebase	VERB
ajbspi-34503	70	9	topical	topical	ADJ
ajbspi-34503	70	10	gel	gel	NOUN
ajbspi-34503	70	11	is	be	AUX
ajbspi-34503	70	12	reassuring	reassure	VERB
ajbspi-34503	70	13	,	,	PUNCT
ajbspi-34503	70	14	with	with	ADP
ajbspi-34503	70	15	no	no	DET
ajbspi-34503	70	16	significant	significant	ADJ
ajbspi-34503	70	17	cytotoxicity	cytotoxicity	NOUN
ajbspi-34503	70	18	observed	observe	VERB
ajbspi-34503	70	19	in	in	ADP
ajbspi-34503	70	20	vitro	vitro	X
ajbspi-34503	70	21	or	or	CCONJ
ajbspi-34503	70	22	adverse	adverse	ADJ
ajbspi-34503	70	23	reactions	reaction	NOUN
ajbspi-34503	70	24	noted	note	VERB
ajbspi-34503	70	25	in	in	ADP
ajbspi-34503	70	26	vivo	vivo	NOUN
ajbspi-34503	70	27	.	.	PUNCT
ajbspi-34503	71	1	this	this	PRON
ajbspi-34503	71	2	suggests	suggest	VERB
ajbspi-34503	71	3	that	that	SCONJ
ajbspi-34503	71	4	the	the	DET
ajbspi-34503	71	5	formulation	formulation	NOUN
ajbspi-34503	71	6	is	be	AUX
ajbspi-34503	71	7	well	well	ADV
ajbspi-34503	71	8	-	-	PUNCT
ajbspi-34503	71	9	tolerated	tolerate	VERB
ajbspi-34503	71	10	and	and	CCONJ
ajbspi-34503	71	11	unlikely	unlikely	ADJ
ajbspi-34503	71	12	to	to	PART
ajbspi-34503	71	13	cause	cause	VERB
ajbspi-34503	71	14	skin	skin	NOUN
ajbspi-34503	71	15	irritation	irritation	NOUN
ajbspi-34503	71	16	or	or	CCONJ
ajbspi-34503	71	17	other	other	ADJ
ajbspi-34503	71	18	adverse	adverse	ADJ
ajbspi-34503	71	19	effects	effect	NOUN
ajbspi-34503	71	20	commonly	commonly	ADV
ajbspi-34503	71	21	associated	associate	VERB
ajbspi-34503	71	22	with	with	ADP
ajbspi-34503	71	23	topical	topical	ADJ
ajbspi-34503	71	24	medications	medication	NOUN
ajbspi-34503	71	25	.	.	PUNCT
ajbspi-34503	72	1	conclusion	conclusion	NOUN
ajbspi-34503	72	2	in	in	ADP
ajbspi-34503	72	3	conclusion	conclusion	NOUN
ajbspi-34503	72	4	,	,	PUNCT
ajbspi-34503	72	5	the	the	DET
ajbspi-34503	72	6	nanoparticle	nanoparticle	NOUN
ajbspi-34503	72	7	-	-	PUNCT
ajbspi-34503	72	8	based	base	VERB
ajbspi-34503	72	9	topical	topical	ADJ
ajbspi-34503	72	10	gel	gel	NOUN
ajbspi-34503	72	11	containing	contain	VERB
ajbspi-34503	72	12	fluconazole	fluconazole	NOUN
ajbspi-34503	72	13	represents	represent	VERB
ajbspi-34503	72	14	a	a	DET
ajbspi-34503	72	15	promising	promising	ADJ
ajbspi-34503	72	16	antifungal	antifungal	ADJ
ajbspi-34503	72	17	treatment	treatment	NOUN
ajbspi-34503	72	18	with	with	ADP
ajbspi-34503	72	19	potential	potential	ADJ
ajbspi-34503	72	20	clinical	clinical	ADJ
ajbspi-34503	72	21	applications	application	NOUN
ajbspi-34503	72	22	.	.	PUNCT
ajbspi-34503	73	1	the	the	DET
ajbspi-34503	73	2	formulation	formulation	NOUN
ajbspi-34503	73	3	offers	offer	VERB
ajbspi-34503	73	4	several	several	ADJ
ajbspi-34503	73	5	advantages	advantage	NOUN
ajbspi-34503	73	6	over	over	ADP
ajbspi-34503	73	7	conventional	conventional	ADJ
ajbspi-34503	73	8	dosage	dosage	NOUN
ajbspi-34503	73	9	forms	form	NOUN
ajbspi-34503	73	10	,	,	PUNCT
ajbspi-34503	73	11	including	include	VERB
ajbspi-34503	73	12	enhanced	enhance	VERB
ajbspi-34503	73	13	drug	drug	NOUN
ajbspi-34503	73	14	delivery	delivery	NOUN
ajbspi-34503	73	15	,	,	PUNCT
ajbspi-34503	73	16	improved	improved	ADJ
ajbspi-34503	73	17	efficacy	efficacy	NOUN
ajbspi-34503	73	18	,	,	PUNCT
ajbspi-34503	73	19	and	and	CCONJ
ajbspi-34503	73	20	favorable	favorable	ADJ
ajbspi-34503	73	21	safety	safety	NOUN
ajbspi-34503	73	22	profile	profile	NOUN
ajbspi-34503	73	23	.	.	PUNCT
ajbspi-34503	74	1	the	the	DET
ajbspi-34503	74	2	successful	successful	ADJ
ajbspi-34503	74	3	formulation	formulation	NOUN
ajbspi-34503	74	4	and	and	CCONJ
ajbspi-34503	74	5	evaluation	evaluation	NOUN
ajbspi-34503	74	6	of	of	ADP
ajbspi-34503	74	7	the	the	DET
ajbspi-34503	74	8	gel	gel	NOUN
ajbspi-34503	74	9	formulation	formulation	NOUN
ajbspi-34503	74	10	pave	pave	VERB
ajbspi-34503	74	11	the	the	DET
ajbspi-34503	74	12	way	way	NOUN
ajbspi-34503	74	13	for	for	SCONJ
ajbspi-34503	74	14	further	further	ADJ
ajbspi-34503	74	15	preclinical	preclinical	ADJ
ajbspi-34503	74	16	and	and	CCONJ
ajbspi-34503	74	17	clinical	clinical	ADJ
ajbspi-34503	74	18	studies	study	NOUN
ajbspi-34503	74	19	to	to	PART
ajbspi-34503	74	20	assess	assess	VERB
ajbspi-34503	74	21	its	its	PRON
ajbspi-34503	74	22	therapeutic	therapeutic	ADJ
ajbspi-34503	74	23	efficacy	efficacy	NOUN
ajbspi-34503	74	24	and	and	CCONJ
ajbspi-34503	74	25	safety	safety	NOUN
ajbspi-34503	74	26	in	in	ADP
ajbspi-34503	74	27	human	human	ADJ
ajbspi-34503	74	28	subjects	subject	NOUN
ajbspi-34503	74	29	.	.	PUNCT
ajbspi-34503	75	1	by	by	ADP
ajbspi-34503	75	2	harnessing	harness	VERB
ajbspi-34503	75	3	the	the	DET
ajbspi-34503	75	4	potential	potential	NOUN
ajbspi-34503	75	5	of	of	ADP
ajbspi-34503	75	6	nanotechnology	nanotechnology	NOUN
ajbspi-34503	75	7	in	in	ADP
ajbspi-34503	75	8	drug	drug	NOUN
ajbspi-34503	75	9	delivery	delivery	NOUN
ajbspi-34503	75	10	,	,	PUNCT
ajbspi-34503	75	11	this	this	DET
ajbspi-34503	75	12	innovative	innovative	ADJ
ajbspi-34503	75	13	formulation	formulation	NOUN
ajbspi-34503	75	14	holds	hold	VERB
ajbspi-34503	75	15	promise	promise	NOUN
ajbspi-34503	75	16	for	for	ADP
ajbspi-34503	75	17	revolutionizing	revolutionize	VERB
ajbspi-34503	75	18	the	the	DET
ajbspi-34503	75	19	management	management	NOUN
ajbspi-34503	75	20	of	of	ADP
ajbspi-34503	75	21	fungal	fungal	ADJ
ajbspi-34503	75	22	infections	infection	NOUN
ajbspi-34503	75	23	and	and	CCONJ
ajbspi-34503	75	24	improving	improve	VERB
ajbspi-34503	75	25	patient	patient	ADJ
ajbspi-34503	75	26	outcomes	outcome	NOUN
ajbspi-34503	75	27	in	in	ADP
ajbspi-34503	75	28	dermatology	dermatology	NOUN
ajbspi-34503	75	29	and	and	CCONJ
ajbspi-34503	75	30	beyond	beyond	ADP
ajbspi-34503	75	31	.	.	PUNCT
ajbspi-34503	76	1	reference	reference	NOUN
ajbspi-34503	76	2	1	1	NUM
ajbspi-34503	76	3	.	.	PUNCT
ajbspi-34503	77	1	basha	basha	PROPN
ajbspi-34503	77	2	bn	bn	PROPN
ajbspi-34503	77	3	,	,	PUNCT
ajbspi-34503	77	4	prakasam	prakasam	PROPN
ajbspi-34503	77	5	k	k	PROPN
ajbspi-34503	77	6	,	,	PUNCT
ajbspi-34503	77	7	goli	goli	PROPN
ajbspi-34503	77	8	d	d	PROPN
ajbspi-34503	77	9	&	&	CCONJ
ajbspi-34503	77	10	college	college	PROPN
ajbspi-34503	77	11	bmr	bmr	PROPN
ajbspi-34503	77	12	.	.	PUNCT
ajbspi-34503	78	1	formulation	formulation	NOUN
ajbspi-34503	78	2	and	and	CCONJ
ajbspi-34503	78	3	evaluation	evaluation	NOUN
ajbspi-34503	78	4	of	of	ADP
ajbspi-34503	78	5	gel	gel	NOUN
ajbspi-34503	78	6	containing	contain	VERB
ajbspi-34503	78	7	fluconazole	fluconazole	NOUN
ajbspi-34503	78	8	-	-	PUNCT
ajbspi-34503	78	9	antifungal	antifungal	ADJ
ajbspi-34503	78	10	agent	agent	NOUN
ajbspi-34503	78	11	.	.	PUNCT
ajbspi-34503	79	1	ijddr	ijddr	PROPN
ajbspi-34503	79	2	.	.	PUNCT
ajbspi-34503	80	1	2010;3(4	2010;3(4	NUM
ajbspi-34503	80	2	)	)	PUNCT
ajbspi-34503	80	3	,	,	PUNCT
ajbspi-34503	80	4	109–128	109–128	NUM
ajbspi-34503	80	5	.	.	NOUN
ajbspi-34503	81	1	2	2	NUM
ajbspi-34503	81	2	.	.	X
ajbspi-34503	81	3	kalpana	kalpana	PROPN
ajbspi-34503	81	4	sp	sp	PROPN
ajbspi-34503	81	5	,	,	PUNCT
ajbspi-34503	81	6	mikolaj	mikolaj	PROPN
ajbspi-34503	81	7	m	m	PROPN
ajbspi-34503	81	8	,	,	PUNCT
ajbspi-34503	81	9	courtney	courtney	PROPN
ajbspi-34503	81	10	ls	ls	PROPN
ajbspi-34503	81	11	,	,	PUNCT
ajbspi-34503	81	12	nicole	nicole	PROPN
ajbspi-34503	81	13	kb	kb	PROPN
ajbspi-34503	81	14	,	,	PUNCT
ajbspi-34503	81	15	priyanka	priyanka	PROPN
ajbspi-34503	81	16	g	g	PROPN
ajbspi-34503	81	17	,	,	PUNCT
ajbspi-34503	81	18	audra	audra	PROPN
ajbspi-34503	81	19	ls	ls	PROPN
ajbspi-34503	81	20	.	.	PROPN
ajbspi-34503	81	21	challenges	challenge	VERB
ajbspi-34503	81	22	andopportunities	andopportunitie	NOUN
ajbspi-34503	81	23	in	in	ADP
ajbspi-34503	81	24	dermal	dermal	NOUN
ajbspi-34503	81	25	/	/	SYM
ajbspi-34503	81	26	transdermal	transdermal	ADJ
ajbspi-34503	81	27	delivery	delivery	NOUN
ajbspi-34503	81	28	.	.	PUNCT
ajbspi-34503	82	1	2010	2010	NUM
ajbspi-34503	82	2	;	;	PUNCT
ajbspi-34503	82	3	1(1	1(1	NUM
ajbspi-34503	82	4	):	):	PUNCT
ajbspi-34503	82	5	109–31	109–31	PROPN
ajbspi-34503	82	6	.	.	PUNCT
ajbspi-34503	83	1	3	3	X
ajbspi-34503	83	2	.	.	X
ajbspi-34503	83	3	gungor	gungor	PROPN
ajbspi-34503	83	4	s	s	PROPN
ajbspi-34503	83	5	,	,	PUNCT
ajbspi-34503	83	6	erdal	erdal	PROPN
ajbspi-34503	83	7	ms	ms	PROPN
ajbspi-34503	83	8	&	&	CCONJ
ajbspi-34503	83	9	aksu	aksu	PROPN
ajbspi-34503	83	10	b.	b.	PROPN
ajbspi-34503	84	1	new	new	ADJ
ajbspi-34503	84	2	formulation	formulation	NOUN
ajbspi-34503	84	3	strategies	strategy	NOUN
ajbspi-34503	84	4	in	in	ADP
ajbspi-34503	84	5	topicalantifungal	topicalantifungal	PROPN
ajbspi-34503	84	6	therapy	therapy	NOUN
ajbspi-34503	84	7	.	.	PUNCT
ajbspi-34503	85	1	journal	journal	PROPN
ajbspi-34503	85	2	of	of	ADP
ajbspi-34503	85	3	cosmetics	cosmetic	NOUN
ajbspi-34503	85	4	,	,	PUNCT
ajbspi-34503	85	5	dermatological	dermatological	ADJ
ajbspi-34503	85	6	sciences	science	NOUN
ajbspi-34503	85	7	and	and	CCONJ
ajbspi-34503	85	8	applications	application	NOUN
ajbspi-34503	85	9	.	.	PUNCT
ajbspi-34503	86	1	2013;3(1	2013;3(1	X
ajbspi-34503	86	2	)	)	PUNCT
ajbspi-34503	86	3	,	,	PUNCT
ajbspi-34503	86	4	56–65	56–65	NUM
ajbspi-34503	86	5	.	.	PUNCT
ajbspi-34503	86	6	4	4	NUM
ajbspi-34503	86	7	.	.	X
ajbspi-34503	86	8	ravikumar	ravikumar	PROPN
ajbspi-34503	86	9	atrp	atrp	PROPN
ajbspi-34503	86	10	.	.	PUNCT
ajbspi-34503	87	1	polymeric	polymeric	ADJ
ajbspi-34503	87	2	nanoparticles	nanoparticle	NOUN
ajbspi-34503	87	3	based	base	VERB
ajbspi-34503	87	4	topical	topical	ADJ
ajbspi-34503	87	5	drug	drug	NOUN
ajbspi-34503	87	6	delivery	delivery	NOUN
ajbspi-34503	87	7	.	.	PUNCT
ajbspi-34503	88	1	asian	asian	ADJ
ajbspi-34503	88	2	journal	journal	PROPN
ajbspi-34503	88	3	of	of	ADP
ajbspi-34503	88	4	biomedical	biomedical	ADJ
ajbspi-34503	88	5	and	and	CCONJ
ajbspi-34503	88	6	pharmaceutical	pharmaceutical	NOUN
ajbspi-34503	88	7	sciences	science	NOUN
ajbspi-34503	88	8	.	.	PUNCT
ajbspi-34503	89	1	2015	2015	NUM
ajbspi-34503	89	2	;	;	PUNCT
ajbspi-34503	89	3	47(5	47(5	X
ajbspi-34503	89	4	)	)	PUNCT
ajbspi-34503	89	5	,	,	PUNCT
ajbspi-34503	90	1	5–12	5–12	NOUN
ajbspi-34503	90	2	.	.	PUNCT
ajbspi-34503	91	1	5	5	NUM
ajbspi-34503	91	2	.	.	X
ajbspi-34503	91	3	abdul	abdul	PROPN
ajbspi-34503	91	4	ra	ra	PROPN
ajbspi-34503	91	5	.	.	PROPN
ajbspi-34503	91	6	fluconazole	fluconazole	PROPN
ajbspi-34503	91	7	for	for	ADP
ajbspi-34503	91	8	the	the	DET
ajbspi-34503	91	9	treatment	treatment	NOUN
ajbspi-34503	91	10	of	of	ADP
ajbspi-34503	91	11	cutaneous	cutaneous	ADJ
ajbspi-34503	91	12	leishmaniasiscaused	leishmaniasiscause	VERB
ajbspi-34503	91	13	by	by	ADP
ajbspi-34503	91	14	leishmania	leishmania	NOUN
ajbspi-34503	91	15	.	.	PUNCT
ajbspi-34503	92	1	n	n	PROPN
ajbspi-34503	93	1	eng	eng	PROPN
ajbspi-34503	93	2	.	.	PUNCT
ajbspi-34503	94	1	j	j	PROPN
ajbspi-34503	94	2	med	med	PROPN
ajbspi-34503	94	3	.	.	PUNCT
ajbspi-34503	94	4	2002	2002	NUM
ajbspi-34503	94	5	;	;	PUNCT
ajbspi-34503	94	6	346(12):211	346(12):211	NOUN
ajbspi-34503	94	7	-	-	SYM
ajbspi-34503	94	8	3	3	NUM
ajbspi-34503	94	9	.	.	NOUN
ajbspi-34503	94	10	6	6	NUM
ajbspi-34503	94	11	.	.	X
ajbspi-34503	94	12	shelke	shelke	PROPN
ajbspi-34503	94	13	sj	sj	PROPN
ajbspi-34503	94	14	,	,	PUNCT
ajbspi-34503	94	15	shinkar	shinkar	PROPN
ajbspi-34503	94	16	d	d	PROPN
ajbspi-34503	94	17	m	m	PROPN
ajbspi-34503	94	18	&	&	CCONJ
ajbspi-34503	94	19	saudagar	saudagar	PROPN
ajbspi-34503	94	20	rb	rb	PROPN
ajbspi-34503	94	21	.	.	PUNCT
ajbspi-34503	94	22	topical	topical	ADJ
ajbspi-34503	94	23	gel	gel	NOUN
ajbspi-34503	94	24	:	:	PUNCT
ajbspi-34503	94	25	a	a	DET
ajbspi-34503	94	26	novel	novel	ADJ
ajbspi-34503	94	27	approach	approach	NOUN
ajbspi-34503	94	28	for	for	ADP
ajbspi-34503	94	29	development	development	NOUN
ajbspi-34503	94	30	of	of	ADP
ajbspi-34503	94	31	topical	topical	ADJ
ajbspi-34503	94	32	drug	drug	NOUN
ajbspi-34503	94	33	delivery	delivery	NOUN
ajbspi-34503	94	34	system	system	NOUN
ajbspi-34503	94	35	.	.	PUNCT
ajbspi-34503	95	1	coden	coden	ADJ
ajbspi-34503	95	2	:	:	PUNCT
ajbspi-34503	95	3	ijptfi	ijptfi	NOUN
ajbspi-34503	95	4	.	.	PUNCT
ajbspi-34503	96	1	2013;5(3	2013;5(3	NUM
ajbspi-34503	96	2	)	)	PUNCT
ajbspi-34503	96	3	,	,	PUNCT
ajbspi-34503	96	4	2739–63	2739–63	NOUN
ajbspi-34503	96	5	.	.	PUNCT
ajbspi-34503	97	1	7	7	X
ajbspi-34503	97	2	.	.	X
ajbspi-34503	97	3	chandel	chandel	PROPN
ajbspi-34503	97	4	ab	ab	PROPN
ajbspi-34503	97	5	,	,	PUNCT
ajbspi-34503	97	6	parashar	parashar	PROPN
ajbspi-34503	97	7	ng	ng	PROPN
ajbspi-34503	97	8	,	,	PUNCT
ajbspi-34503	97	9	kumar	kumar	PROPN
ajbspi-34503	97	10	a	a	PROPN
ajbspi-34503	97	11	,	,	PUNCT
ajbspi-34503	97	12	sharma	sharma	PROPN
ajbspi-34503	97	13	v.	v.	ADP
ajbspi-34503	97	14	an	an	DET
ajbspi-34503	97	15	overview	overview	NOUN
ajbspi-34503	97	16	on	on	ADP
ajbspi-34503	97	17	gel	gel	NOUN
ajbspi-34503	97	18	formulation	formulation	NOUN
ajbspi-34503	97	19	.	.	PUNCT
ajbspi-34503	98	1	int	int	NOUN
ajbspi-34503	98	2	.	.	PUNCT
ajbspi-34503	99	1	j.	j.	PROPN
ajbspi-34503	99	2	pharmacyrev	pharmacyrev	PROPN
ajbspi-34503	99	3	.	.	PUNCT
ajbspi-34503	100	1	res.2013	res.2013	NUM
ajbspi-34503	100	2	;	;	PUNCT
ajbspi-34503	100	3	vol1:18	vol1:18	NOUN
ajbspi-34503	100	4	-	-	SYM
ajbspi-34503	100	5	22	22	NUM
ajbspi-34503	100	6	.	.	NOUN
ajbspi-34503	101	1	8	8	NUM
ajbspi-34503	101	2	.	.	PUNCT
ajbspi-34503	101	3	saroha	saroha	PROPN
ajbspi-34503	101	4	k	k	PROPN
ajbspi-34503	101	5	,	,	PUNCT
ajbspi-34503	101	6	singh	singh	PROPN
ajbspi-34503	101	7	s	s	PROPN
ajbspi-34503	101	8	,	,	PUNCT
ajbspi-34503	101	9	aggarwal	aggarwal	PROPN
ajbspi-34503	101	10	a	a	DET
ajbspi-34503	101	11	,	,	PUNCT
ajbspi-34503	101	12	nanda	nanda	ADV
ajbspi-34503	101	13	s.	s.	PROPN
ajbspi-34503	101	14	transdermal	transdermal	PROPN
ajbspi-34503	101	15	gels	gel	NOUN
ajbspi-34503	101	16	-	-	PUNCT
ajbspi-34503	101	17	an	an	DET
ajbspi-34503	101	18	alternative	alternative	ADJ
ajbspi-34503	101	19	vehicle	vehicle	NOUN
ajbspi-34503	101	20	for	for	ADP
ajbspi-34503	101	21	drug	drug	NOUN
ajbspi-34503	101	22	delivery	delivery	NOUN
ajbspi-34503	101	23	.	.	PUNCT
ajbspi-34503	102	1	int.j	int.j	PROPN
ajbspi-34503	102	2	.	.	PUNCT
ajbspi-34503	102	3	pharm	pharm	PROPN
ajbspi-34503	102	4	.	.	PUNCT
ajbspi-34503	103	1	chem	chem	PROPN
ajbspi-34503	103	2	.	.	PUNCT
ajbspi-34503	104	1	biol	biol	PROPN
ajbspi-34503	104	2	.	.	PUNCT
ajbspi-34503	105	1	sci	sci	PROPN
ajbspi-34503	105	2	.	.	PROPN
ajbspi-34503	105	3	2013	2013	NUM
ajbspi-34503	105	4	;	;	PUNCT
ajbspi-34503	105	5	3(3	3(3	NUM
ajbspi-34503	105	6	)	)	PUNCT
ajbspi-34503	105	7	,	,	PUNCT
ajbspi-34503	105	8	pp495	pp495	PROPN
ajbspi-34503	105	9	-	-	SYM
ajbspi-34503	105	10	503	503	NUM
ajbspi-34503	105	11	.	.	NOUN
ajbspi-34503	106	1	9	9	NUM
ajbspi-34503	106	2	.	.	X
ajbspi-34503	106	3	indora	indora	PROPN
ajbspi-34503	106	4	n	n	CCONJ
ajbspi-34503	106	5	,	,	PUNCT
ajbspi-34503	106	6	kaushikm	kaushikm	PROPN
ajbspi-34503	106	7	d.	d.	PROPN
ajbspi-34503	106	8	design	design	PROPN
ajbspi-34503	106	9	,	,	PUNCT
ajbspi-34503	106	10	development	development	NOUN
ajbspi-34503	106	11	and	and	CCONJ
ajbspi-34503	106	12	evaluation	evaluation	NOUN
ajbspi-34503	106	13	of	of	ADP
ajbspi-34503	106	14	ethosomal	ethosomal	ADJ
ajbspi-34503	106	15	gel	gel	NOUN
ajbspi-34503	106	16	of	of	ADP
ajbspi-34503	106	17	fluconazole	fluconazole	NOUN
ajbspi-34503	106	18	for	for	ADP
ajbspi-34503	106	19	topical	topical	ADJ
ajbspi-34503	106	20	fungal	fungal	ADJ
ajbspi-34503	106	21	infection	infection	NOUN
ajbspi-34503	106	22	.	.	PUNCT
ajbspi-34503	107	1	int	int	NOUN
ajbspi-34503	108	1	j	j	PROPN
ajbspi-34503	108	2	eng	eng	PROPN
ajbspi-34503	108	3	sci	sci	PROPN
ajbspi-34503	108	4	invent	invent	PROPN
ajbspi-34503	108	5	res	res	PROPN
ajbspi-34503	108	6	dev	dev	PROPN
ajbspi-34503	108	7	.	.	PROPN
ajbspi-34503	108	8	2015	2015	NUM
ajbspi-34503	108	9	;	;	PUNCT
ajbspi-34503	109	1	i(viii):280	i(viii):280	PROPN
ajbspi-34503	109	2	.	.	PROPN
ajbspi-34503	110	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34503	110	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	VERB
ajbspi-34503	110	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34503	110	4	volume	volume	NOUN
ajbspi-34503	110	5	04	04	NUM
ajbspi-34503	110	6	issue	issue	NOUN
ajbspi-34503	110	7	03	03	NUM
ajbspi-34503	110	8	-	-	SYM
ajbspi-34503	110	9	2024	2024	NUM
ajbspi-34503	110	10	17	17	NUM
ajbspi-34503	110	11	american	american	ADJ
ajbspi-34503	110	12	journal	journal	PROPN
ajbspi-34503	110	13	of	of	ADP
ajbspi-34503	110	14	biomedical	biomedical	PROPN
ajbspi-34503	110	15	science	science	PROPN
ajbspi-34503	110	16	&	&	CCONJ
ajbspi-34503	110	17	pharmaceutical	pharmaceutical	PROPN
ajbspi-34503	110	18	innovation	innovation	NOUN
ajbspi-34503	110	19	(	(	PUNCT
ajbspi-34503	110	20	issn	issn	PROPN
ajbspi-34503	110	21	–	–	PUNCT
ajbspi-34503	110	22	2771	2771	NUM
ajbspi-34503	110	23	-	-	SYM
ajbspi-34503	110	24	2753	2753	NUM
ajbspi-34503	110	25	)	)	PUNCT
ajbspi-34503	110	26	volume	volume	NOUN
ajbspi-34503	110	27	04	04	NUM
ajbspi-34503	110	28	issue	issue	NOUN
ajbspi-34503	110	29	03	03	NUM
ajbspi-34503	110	30	pages	page	NOUN
ajbspi-34503	110	31	:	:	PUNCT
ajbspi-34503	110	32	9	9	NUM
ajbspi-34503	110	33	-	-	SYM
ajbspi-34503	110	34	17	17	NUM
ajbspi-34503	110	35	sjif	sjif	NOUN
ajbspi-34503	110	36	impact	impact	NOUN
ajbspi-34503	110	37	factor	factor	NOUN
ajbspi-34503	110	38	(	(	PUNCT
ajbspi-34503	110	39	2021	2021	NUM
ajbspi-34503	110	40	:	:	PUNCT
ajbspi-34503	110	41	5	5	NUM
ajbspi-34503	110	42	.	.	NOUN
ajbspi-34503	110	43	705	705	NUM
ajbspi-34503	110	44	)	)	PUNCT
ajbspi-34503	110	45	(	(	PUNCT
ajbspi-34503	110	46	2022	2022	NUM
ajbspi-34503	110	47	:	:	PUNCT
ajbspi-34503	110	48	5	5	NUM
ajbspi-34503	110	49	.	.	NOUN
ajbspi-34503	110	50	705	705	NUM
ajbspi-34503	110	51	)	)	PUNCT
ajbspi-34503	110	52	(	(	PUNCT
ajbspi-34503	110	53	2023	2023	NUM
ajbspi-34503	110	54	:	:	PUNCT
ajbspi-34503	110	55	6.534	6.534	NUM
ajbspi-34503	110	56	)	)	PUNCT
ajbspi-34503	110	57	oclc	oclc	PROPN
ajbspi-34503	110	58	–	–	PUNCT
ajbspi-34503	110	59	1121105677	1121105677	NUM
ajbspi-34503	110	60	publisher	publisher	NOUN
ajbspi-34503	110	61	:	:	PUNCT
ajbspi-34503	110	62	oscar	oscar	NOUN
ajbspi-34503	110	63	publishing	publishing	NOUN
ajbspi-34503	110	64	services	service	NOUN
ajbspi-34503	110	65	servi	servi	PROPN
ajbspi-34503	110	66	10	10	NUM
ajbspi-34503	110	67	.	.	PUNCT
ajbspi-34503	111	1	guinea	guinea	PROPN
ajbspi-34503	111	2	j	j	PROPN
ajbspi-34503	111	3	,	,	PUNCT
ajbspi-34503	111	4	sanchez	sanchez	PROPN
ajbspi-34503	111	5	-	-	PUNCT
ajbspi-34503	111	6	somolinos	somolinos	PROPN
ajbspi-34503	111	7	m	m	PROPN
ajbspi-34503	111	8	,	,	PUNCT
ajbspi-34503	111	9	cuevas	cuevas	PROPN
ajbspi-34503	111	10	o	o	PROPN
ajbspi-34503	111	11	,	,	PUNCT
ajbspi-34503	111	12	pelaez	pelaez	PROPN
ajbspi-34503	111	13	,	,	PUNCT
ajbspi-34503	111	14	t	t	PROPN
ajbspi-34503	111	15	,	,	PUNCT
ajbspi-34503	111	16	bouz	bouz	NOUN
ajbspi-34503	111	17	,	,	PUNCT
ajbspi-34503	111	18	e.	e.	PROPN
ajbspi-34503	111	19	fluconazole	fluconazole	PROPN
ajbspi-34503	111	20	resistance	resistance	NOUN
ajbspi-34503	111	21	mechanisms	mechanism	NOUN
ajbspi-34503	111	22	incandida	incandida	PROPN
ajbspi-34503	111	23	krusei	krusei	VERB
ajbspi-34503	111	24	:	:	PUNCT
ajbspi-34503	111	25	the	the	DET
ajbspi-34503	111	26	contribution	contribution	NOUN
ajbspi-34503	111	27	of	of	ADP
ajbspi-34503	111	28	efflux	efflux	NOUN
ajbspi-34503	111	29	-	-	PUNCT
ajbspi-34503	111	30	pumps	pump	NOUN
ajbspi-34503	111	31	.	.	PUNCT
ajbspi-34503	112	1	med	med	PROPN
ajbspi-34503	112	2	mycol	mycol	NOUN
ajbspi-34503	112	3	.	.	PUNCT
ajbspi-34503	113	1	2006	2006	NUM
ajbspi-34503	113	2	sep	sep	NOUN
ajbspi-34503	113	3	;	;	PUNCT
ajbspi-34503	113	4	44(6):5758	44(6):5758	X
ajbspi-34503	113	5	.	.	PUNCT
ajbspi-34503	114	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34503	114	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-34503	114	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN